Yuji Inagaki, Jun-ichi Kido, Yasufumi Nishikawa, Rie Kido, Eijiro Sakamoto, Mika Bandou, Koji Naruishi, Toshihiko Nagata and Hiromichi Yumoto : Gan-Lu-Yin (Kanroin), Traditional Chinese Herbal Extracts, Reduces Osteoclast Differentiation In Vitro and Prevents Alveolar Bone Resorption in Rat Experimental Periodontitis, Jul. 2021.
2.
Koji Naruishi and Toshihiko Nagata : 腎臓と他臓器連関を考える 臓器連関の実態 腎臓-口腔連関, Nankodo, Aug. 2020.
3.
Koji Naruishi and Toshihiko Nagata : ザ・ペリオドントロジー「歯周病と慢性腎臓病(CKD)」, 永末書店, Feb. 2019.
4.
Timothy C Thompson, Saladihan A Tahir, Likun Li, Masami Watanabe, Koji Naruishi, Guang Yang and Ken-ichi Tabata : Local and distant effects of caveolin-1 on prostate cancer tumor progression, Springer Science + Business Media, Mar. 2011.
5.
Timme L Terry, Fujita Tetsuo, Wang Hongyu, Koji Naruishi, Kadmon Dov and Thompson C Timothy : Cytokine Gene Therapy for Genitourinary Cancer, The Humana Press, 2007.
Academic Paper (Judged Full Paper):
1.
Jun-ichi Kido, Yuka Hiroshima, Rie Kido, Kaya Yoshida, Yuji Inagaki, Koji Naruishi, Kazuaki Kajimoto, Masatoshi Kataoka, Yasuo Shinohara and Hiromichi Yumoto : Lipocalin 2, synthesized using a cell-free protein synthesis system and encapsulated into liposomes, inhibits the adhesion of Porphyromonas gingivalis to human oral epithelial cells., Journal of Periodontal Research, Vol.58, No.2, 262-273, 2023.
Yasufumi Nishikawa, Yoritoki Tomotake, Hiromichi Kawano, Koji Naruishi, Jun-ichi Kido, Yuka Hiroshima, Akikazu Murakami, Tetsuo Ichikawa and Hiromichi Yumoto : Effects of Candidalysin Derived from Candida albicans on the Expression of Pro-Inflammatory Mediators in Human Gingival Fibroblasts, International Journal of Molecular Sciences, Vol.24, No.4, 3256, 2023.
Koji Naruishi : Biological Roles of Fibroblasts in Periodontal Diseases., Cells, Vol.11, No.21, 3345, 2022.
(Summary)
Periodontal diseases include periodontitis and gingival overgrowth. Periodontitis is a bacterial infectious disease, and its pathological cascade is regulated by many inflammatory cytokines secreted by immune or tissue cells, such as interleukin-6. In contrast, gingival overgrowth develops as a side effect of specific drugs, such as immunosuppressants, anticonvulsants, and calcium channel blockers. Human gingival fibroblasts (HGFs) are the most abundant cells in gingival connective tissue, and human periodontal ligament fibroblasts (HPLFs) are located between the teeth and alveolar bone. HGFs and HPLFs are both crucial for the remodeling and homeostasis of periodontal tissue, and their roles in the pathogenesis of periodontal diseases have been examined for 25 years. Various responses by HGFs or HPLFs contribute to the progression of periodontal diseases. This review summarizes the biological effects of HGFs and HPLFs on the pathogenesis of periodontal diseases.
Koji Naruishi, Chie Wada -Mihara, Keiji Oishi and Toshihiko Nagata : Dental students' awareness after clinical training between dental treatment and systemic health: A questionnaire-based survey, Frontiers in Dental Medicine, 2022.
Yuji Inagaki, Jun-ichi Kido, Yasufumi Nishikawa, Rie Kido, Eijiro Sakamoto, Mika Bandou, Koji Naruishi, Toshihiko Nagata and Hiromichi Yumoto : Gan-Lu-Yin (Kanroin), traditional Chinese herbal extracts, reduces osteoclast differentiation in vitro and prevents alveolar bone resorption in rat experimental periodontitis, Journal of Clinical Medicine, Vol.10, No.3, 386, 2021.
(Summary)
Gan-Lu-Yin (GLY), a traditional Chinese herbal medicine, shows therapeutic effects on periodontitis, but that mechanism is not well known. This study aims to clarify the precise mechanism by investigating the inhibitory effects of GLY extracts on osteoclastogenesis in vitro and on bone resorption in periodontitis in vivo. RAW264.7 cells are cultured with soluble receptor activator of nuclear factor-kappa B (sRANKL) and GLY extracts (0.01-1.0 mg/mL), and stained for tartrate-resistant acid phosphatase (TRAP) to evaluate osteoclast differentiation. Experimental periodontitis is induced by placing a nylon ligature around the second maxillary molar in rats, and rats are administered GLY extracts (60 mg/kg) daily for 20 days. Their maxillae are collected on day 4 and 20, and the levels of alveolar bone resorption and osteoclast differentiation are estimated using micro-computed tomography (CT) and histological analysis, respectively. In RAW264.7 cells, GLY extracts significantly inhibit sRANKL-induced osteoclast differentiation at a concentration of more than 0.05 mg/mL. In experimental periodontitis, administering GLY extracts significantly decreases the number of TRAP-positive osteoclasts in the alveolar bone on day 4, and significantly inhibits the ligature-induced bone resorption on day 20. These results show that GLY extracts suppress bone resorption by inhibiting osteoclast differentiation in experimental periodontitis, suggesting that GLY extracts are potentially useful for oral care in periodontitis.
Yasufumi Nishikawa, Koji Naruishi, Jun-ichi Kido and Hiromichi Yumoto : Inhibitory Effects of Sudachitin on the Production of Inflammation-related Molecules in Human Gingival Fibroblasts Cultured under High Glucose Conditions, The Japanese Journal of Conservative Dentistry, Vol.63, No.6, 503-511, 2020.
Koji Naruishi, Eijiro Sakamoto, Takahisa Ikuta, Rie Kido, Jun-ichi Kido and Hiromichi Yumoto : Evaluation of educational effects of periodontology by lectures and phantom training in dental students, The Japanese Journal of Conservative Dentistry, Vol.63, No.1, 22-29, 2020.
(Summary)
<p> Purpose: In the undergraduate educational curriculum of dentistry, there are two main teaching/learning methods for dental students before clinical training: traditional lectures and phantom training. The purpose of this study was to explore effective educational systems for periodontology by examining the test results of both lectures and phantom training.</p><p> Methods: Both a written test and a practical test of periodontology were administered to students of dentistry. A total of 43 dental students of Tokushima University Dental School were recruited. Written tests were performed before and after the lectures on periodontology. A practical test of scaling and root planing was performed after phantom training. Associations between the results of the written test and practical test were analyzed statistically. P values of less than 0.05 were considered statistically significant.</p><p> Results: The results of the written tests after lectures were higher than those before lectures. A significant positive correlation was found between the results of the written test and practical test.</p><p> Conclusion: In the students' education on periodontology, the results of the practical test were correlated statistically to the results of the written test. These findings may contribute to establishing effective educational systems for periodontology in dentistry.</p>
Masami Ninomiya, Mari Hashimoto, Kouji Yamanouchi, Yoshiaki Fukumura, Toshihiko Nagata and Koji Naruishi : Relationship of oral conditions to the incidence of infective endocarditis in periodontitis patients with valvular heart disease: a cross-sectional study., Clinical Oral Investigations, Vol.24, No.2, 833-840, 2020.
(Summary)
The patients with IE had fewer remaining teeth, more advanced bone resorption compared with those of patients without IE. These findings suggest a possible association between the occurrence of IE and periodontal infection.
Koji Naruishi : Carotenoids and Periodontal Infection., Nutrients, Vol.12, No.1, E269, 2020.
(Summary)
) is associated with increased atherosclerosis, diabetes mellitus, and other systemic diseases through blood stream. On the other hand, carotenoids belong among phytochemicals that are responsible for different colors of the foods. It is important to examine whether carotenoids are effective to the inhibition of periodontal infection/inflammation cascades. This review summarizes the advanced state of knowledge about suppression of periodontal infection by several carotenoids. A series of findings suggest that carotenoids intake may provide novel strategy for periodontitis treatment, although further study will be needed.
Kohei Nonaka, Mika Bandou, Eijiro Sakamoto, Yuji Inagaki, Koji Naruishi, Hiromichi Yumoto and Jun-ichi Kido : 6-Shogaol inhibits advanced glycation end-products-induced IL-6 and ICAM-1 expression by regulating oxidative responses in human gingival fibroblasts, Molecules, Vol.24, No.20, e3705, 2019.
(Summary)
Advanced glycation end-products (AGEs) cause diabetes mellitus (DM) complications and accumulate more highly in periodontal tissues of patients with periodontitis and DM. AGEs aggravate periodontitis with DM by increasing the expression of inflammation-related factors in periodontal tissues. 6-Shogaol, a major compound in ginger, has anti-inflammatory and anti-oxidative activities. However, the influence of shogaol on DM-associated periodontitis is not well known. In this study, the effects of 6-shogaol on AGEs-induced oxidative and anti-oxidative responses, and IL-6 and ICAM-1 expression in human gingival fibroblasts (HGFs) were investigated. When HGFs were cultured with 6-shogaol and AGEs, the activities of reactive oxygen species (ROS) and antioxidant enzymes (heme oxygenase-1 [HO-1] and NAD(P)H quinone dehydrogenase 1 [NQO1]), and IL-6 and ICAM-1 expressions were investigated. RAGE expression and phosphorylation of MAPKs and NF-κB were examined by western blotting. 6-Shogaol significantly inhibited AGEs-induced ROS activity, and increased HO-1 and NQO1 levels compared with the AGEs-treated cells. The AGEs-stimulated expression levels of receptor of AGE (RAGE), IL-6 and ICAM-1 and the phosphorylation of p38, ERK and p65 were attenuated by 6-shogaol. These results suggested that 6-shogaol inhibits AGEs-induced inflammatory responses by regulating oxidative and anti-oxidative activities and may have protective effects on periodontitis with DM.
Eijiro Sakamoto, Jun-ichi Kido, Ryosuke Takagi, Yuji Inagaki, Koji Naruishi, Toshihiko Nagata and Hiromichi Yumoto : Advanced glycation end-product 2 and Porphyromonas gingivalis lipopolysaccharide increase sclerostin expression in mouse osteocyte-like cells, Bone, Vol.122, 22-30, 2019.
(Summary)
Sclerostin is a secreted glycoprotein that is mainly expressed in osteocytes, exerts negative effects on bone formation, and is present at elevated levels in diabetes mellitus (DM). Periodontitis is an infectious disease caused by periodontopathic bacteria, a complication of DM, and sometimes associated with severe inflammation and alveolar bone resorption. Advanced glycation end-products (AGEs) are a major pathogen in DM complications and adversely influence periodontitis in DM patients. In the present study, the effects of AGE2 and Porphyromonas gingivalis lipopolysaccharide (P-LPS) on the expression of sclerostin in mouse osteocyte-like cells (MLO-Y4-A2 cells) and its function in osteoblast differentiation were investigated. AGE2 and P-LPS up-regulated the expressions of receptor of AGE (RAGE) and Toll-like receptor 2 (TLR2), respectively, and significantly up-regulated that of sclerostin and interleukin 6 (IL-6) in osteocytes. Sclerostin, RAGE and TLR2 levels were synergistically increased by AGE2 and P-LPS. The siRNAs of RAGE and TLR2 significantly inhibited AGE2- and P-LPS-induced sclerostin expression. AGE2 up-regulated sclerostin expression in osteocyte-like cells via the RAGE, ERK and JNK, and NF-κB signal pathways. On the other hand, P-LPS elevated sclerostin levels via the TLR2, JNK and p38, and NF-κB signal pathways. When osteocytes pre-treated with AGE2 and P-LPS and osteoblastic cells (MC3T3-E1) were co-cultured in the medium with a sclerostin-neutralizing antibody, AGE2- and P-LPS-induced decreases in alkaline phosphatase activity and Runx2 expression in osteoblastic cells were significantly inhibited by the sclerostin-neutralizing antibody. These results suggest that AGE2 and P-LPS influence bone metabolism and inflammation through the regulation of sclerostin expression, and may aggravate periodontitis with DM.
Jung-Hwan Lew, Koji Naruishi, Yukari Kajiura, Yasufumi Nishikawa, Takahisa Ikuta, Jun-ichi Kido and Toshihiko Nagata : High Glucose-Mediated Cytokine Regulation in Gingival Fibroblasts and THP-1 Macrophage: a Possible Mechanism of Severe Periodontitis with Diabetes., Cellular Physiology and Biochemistry, Vol.50, No.3, 973-986, 2018.
(Summary)
Diabetic conditions such as HG induce IL-1 and sIL-6R production from macrophages in inflammatory periodontal tissues and may exacerbate the periodontitis synergistically via MMP-1 production from HGFs.
Kohei Nonaka, Yukari Kajiura, Mika Bandou, Eijiro Sakamoto, Yuji Inagaki, JH Lew, Koji Naruishi, Takahisa Ikuta, Kaya Yoshida, Tesuo Kobayashi, Hiromasa Yoshie, Toshihiko Nagata and Jun-ichi Kido : Advanced glycation end-products increase IL-6 and ICAM-1 expression via RAGE, MAPK and NF-kB pathways in human gingival fibroblasts, Journal of Periodontal Research, Vol.53, No.3, 334-344, 2018.
(Summary)
Diabetes mellitus (DM) is a risk factor for periodontal diseases and may exacerbate the progression of the pathogenesis of periodontitis. Advanced glycation end-products (AGEs) cause DM complications relative to levels of glycemic control and larger amounts accumulate in the periodontal tissues of patients with periodontitis and DM. In the present study, we investigated the effects of AGEs on the expression of inflammation-related factors in human gingival fibroblasts (HGFs) to elucidate the impact of AGEs on DM-associated periodontitis. HGFs were cultured with or without AGEs. Cell viability was examined, and RNA and protein fractions were isolated from AGE-treated cells. The expression of interleukin (IL)-6, intercellular adhesion molecule-1 (ICAM-1), and the receptor for AGE (RAGE) was investigated using reverse transcription-polymerase chain reaction, quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assay, and reactive oxygen species activity was measured using a kit with 2',7'-dichlorofluorescin diacetate. Human monocytic cells (THP-1) labeled with a fluorescent reagent were co-cultured with HGFs treated with AGEs and IL-6 siRNA, and the adhesive activity of THP-1 cells to HGFs was assessed. The expression of IL-6 and ICAM-1 was examined when HGFs were pretreated with recombinant human IL-6, the siRNAs of RAGE and IL-6, and inhibitors of MAPK and NF-κB, and then cultured with and without AGEs. The phosphorylation of MAPK and NF-κB was assessed using western blotting. AGEs increased the mRNA and protein expressions of RAGE, IL-6, ICAM-1 and reactive oxygen species activity in HGFs, and promoted the adhesion of THP-1 cells to HGFs, but had no effect on cell viability until 72 hours. Recombinant human IL-6 increased ICAM-1 expression in HGFs, while the siRNAs of RAGE and IL-6 inhibited AGE-induced IL6 and ICAM1 mRNA expression, and IL-6 siRNA depressed AGE-induced THP-1 cell adhesion. AGEs increased the phosphorylation of p38 and ERK MAPKs, p65 NF-κB and IκBα, while inhibitors of p38, ERK MAPKs and NF-κB significantly decreased AGE-induced IL-6 and ICAM-1 expression. AGEs increase IL-6 and ICAM-1 expression via the RAGE, MAPK and NF-κB pathways in HGFs and may exacerbate the progression of the pathogenesis of periodontal diseases.
(Keyword)
Antigens, Neoplasm / Diabetes Complications / Fibroblasts / Gingiva / Glycation End Products, Advanced / Humans / Intercellular Adhesion Molecule-1 / Interleukin-6 / MAP Kinase Signaling System / Mitogen-Activated Protein Kinase Kinases / Mitogen-Activated Protein Kinases / NF-kappa B / Periodontitis / Phosphorylation / Reactive Oxygen Species / THP-1 Cells
Koji Naruishi, Hiromichi Yumoto and Jun-ichi Kido : Clinical effects of low body mass index on geriatric status in elderly patients., Experimental Gerontology, Vol.110, 86-91, 2018.
(Summary)
Low BMI might be a useful parameter to evaluate the geriatric status, and the viewpoint would contribute to decide the care plan for the good end-of-life of elderly.
Yukari Kajiura, Yasufumi Nishikawa, Hwan Jung Lew, Jun-ichi Kido, Toshihiko Nagata and Koji Naruishi : b-carotene suppresses Porphyromonas gingivalis lipopolysaccharide-mediated cytokine production in THP-1 monocytes cultured with high glucose condition., Cell Biology International, Vol.42, No.1, 105-111, 2018.
(Summary)
Periodontitis is associated with development of diabetes mellitus. Although lipopolysaccharide (LPS) of Porphyromonas gingivalis (Pg), a major pathogen of periodontitis, may lead the progression of diabetes complications, the precise mechanisms are unclear. We, therefore, investigated the effects of β-carotene on production of Pg LPS-induced inflammatory cytokines in human monocytes cultured high glucose (HG) condition. THP-1 cells were cultured under 5.5 mM or 25 mM glucose conditions, and cells were stimulated with Pg LPS. To investigate the productivity of TNF-α, IL-6, and MCP-1, cell supernatants were collected for ELISA. To examine the effects of NF-kB signals on cytokine production, Bay11-7082 was used. HG enhanced Pg LPS-induced production of TNF-α, IL-6, and MCP-1 via NF-kB signals in THP-1. β-carotene suppressed the enhancement of the Pg LPS-induced cytokine production in THP-1 via NF-κB inactivation. Our results suggest that β-carotene might be a potential anti-inflammatory nutrient for circulating Pg LPS-mediated cytokine production in diabetic patients with periodontitis.
Koji Naruishi and Yasufumi Nishikawa : Swallowing impairment is a significant factor for predicting life prognosis of elderly at the end of life., Aging Clinical and Experimental Research, Vol.30, No.1, 77-80, 2018.
(Summary)
For judgement of life prognosis, the condition of being frail such as impaired swallowing function might be a useful factor, and the viewpoint would contribute to decide the treatment plan for the good end-of-life care of elderly.
Chie Wada -Mihara, Hiroyuki Seto, Hirofumi Ohba, Kaku Tokunaga, Jun-ichi Kido, Toshihiko Nagata and Koji Naruishi : Local administration of calcitonin inhibits alveolar bone loss in an experimental periodontitis in rats., Biomedicine & Pharmacotherapy, Vol.97, No.1, 765-770, 2018.
(Summary)
Calcitonin (CTN), a calcium regulatory hormone, promotes calcium diuresis from the kidney and suppresses bone resorption. The objective of this study was to evaluate whether the topical and intermittent application of CTN inhibits alveolar bone resorption using ligature-induced experimental periodontitis in rats. Experimental periodontitis was induced by placing a nylon ligature around maxillary molars of 8-week-old male Wistar rats for 20 days. Thirty-two rats were divided into four groups: basal sham control group, periodontitis group, periodontitis plus 0.2 U CTN (low dose), and periodontitis plus 1.0 U CTN (high dose) group. To investigate the effects of CTN on alveolar bone resorption, CTN was topically injected into the palatal gingivae every 2 days after ligature removal (day 0). Micro-computed tomography (CT) analysis was performed for linear parameter assessment of alveolar bone on day 5 and day 14. Periodontal tissues were examined histo-pathologically to assess the differences among the study groups. Micro-CT images showed that alveolar bone resorption was induced statistically around the molar of ligatured rats on day 5 and day 14. The amount of bone resorption was more severe on day 14 than that on day 5. On day 5, only high-dose CTN treatment significantly suppressed bone resorption. In addition, both doses of CTN significantly suppressed bone resorption on day 14. Histological examination clarified that there were fewer TRAP-positive cells in the CTN treatment groups than in the periodontitis group on day 5. Local administration of CTN decreased alveolar bone resorption by regulating osteoclast activation in rats with periodontitis.
Yuka Hiroshima, Eijiro Sakamoto, Kaya Yoshida, Kaori Abe, Koji Naruishi, Takenori Yamamoto, Yasuo Shinohara, Jun-ichi Kido and Carolyn L Geczy : Advanced glycation end-products and Porphyromonas gingivalis lipopolysaccharide increase calprotectin expression in human gingival epithelial cells., Journal of Cellular Biochemistry, Vol.119, No.2, 1591-1603, 2018.
(Summary)
Accumulation of advanced glycation end-products (AGEs) in periodontal tissues of patients with diabetes mellitus aggravates periodontitis, but the mechanisms are unknown. Calprotectin, a heterocomplex of S100A8 and S100A9 proteins, is a constitutive cytoplasmic component of healthy gingival epithelial cells. This study aimed at investigating the effects of AGE and Porphyromonas gingivalis lipopolysaccharide (PgLPS) on calprotectin expression in the human gingival epithelial cell line OBA-9. AGE and PgLPS increased the expression of S100A8 and S100A9 mRNAs, and AGE + PgLPS co-stimulation amplified their expression in OBA-9 cells. A higher concentration of calprotectin in cell lysates was also induced by stimulation with AGE and/or PgLPS. S100A8 was mainly translocated from the nucleus to the cytoplasm by AGE stimulation, while cytoplasmic localization of S100A9 was not altered following stimulation with AGE and/or PgLPS. Calprotectin was found in the cytoplasm of BSA-treated cells, but cytoplasmic and nuclear localization was observed following stimulation with AGE and/or PgLPS. AGE-induced S100A8, and S100A9 mRNA expression was partially suppressed by RAGE-specific siRNA. In contrast, PgLPS-induced S100A8 and S100A9 mRNA expression was strongly suppressed by TLR2-specific siRNA. Furthermore, the inhibition of p38, JNK MAPK, and NF-κB attenuated AGE- and PgLPS-induced S100A8 and S100A9 mRNA expression. Taken together, these results demonstrate that AGE acts in synergy with PgLPS to stimulate RAGE and TLR2 expression and activate p38, JNK MAPK, and NF-κB signaling pathways, resulting in increased activation of calprotectin (S100A8/S100A9) in human gingival epithelial cells. Our results suggest that calprotectin may be involved in the pathogenesis of diabetic periodontitis. This article is protected by copyright. All rights reserved.
Yasufumi Nishikawa, Yukari Kajiura, Hwan Jung Lew, Jun-ichi Kido, Toshihiko Nagata and Koji Naruishi : Calprotectin Induces IL-6 and MCP-1 Production via Toll-Like Receptor 4 Signaling in Human Gingival Fibroblasts., Journal of Cellular Physiology, Vol.232, No.7, 1862-1871, 2017.
Koji Naruishi, Keiji Oishi, Yuuji Inagaki, Masumi Horibe, Mika Bandou, Masami Ninomiya, K Kawahara, J Minakuchi, S Kawashima, K Shima, Jun-ichi Kido and Toshihiko Nagata : Association between Periodontal Condition and Kidney Dysfunction in Japanese Adults: A Cross-Sectional Study, Clinical and Experimental Dental Research, Vol.2, No.2, 1-8, 2016.
K Takeuchi-Hatanaka, T Yasuda, Koji Naruishi, K Katsuragi-Fuke, J Inubushi, H Ootsuki, H Maeda and S Takashiba : Effects of new over-the-counter periodontal ointment-containing applicator with single-tuft brush on cytokine levels in gingival crevicular fluid during supportive periodontal therapy phase: a randomized double-blind clinical trial., Journal of Periodontal Research, Vol.51, No.3, 321-331, 2016.
(Summary)
This OTC medication is biochemically effective for steady chronic periodontitis in the supportive periodontal therapy phase.
Koji Naruishi, Yukari Kajiura, 西川 泰史, Mika Bandou, Jun-ichi Kido and Toshihiko Nagata : Inhibitory Effects of Cryptotanshinone on Inflammation-related Molecules in Human Gingival Fibroblasts, The Japanese Journal of Conservative Dentistry, Vol.58, No.3, 212-218, 2015.
(Summary)
Purpose: Cryptotanshinone (CPT) isolated from the root of an Asian medicinal plant, Salvia miltiorrhiza bunge, acts as a potent anti-tumor or anti-inflammatory agent in vitro. However, the effects of CPT on the progression of periodontitis are still unknown. This study investigated the effects of CPT on the production of inflammation-related molecules in human gingival fibroblasts. Methods: Human gingival fibroblasts (HGFs), CRL-2014TM (ATCC), were used. Cytotoxicity of the cells by CPT was examined. Dead cells stained by trypan blue were counted and analyzed. Next, the levels of IL-6 and VEGF in IL-1β-treated cells with or without CPT were measured using ELISA kits. The productivity of cathepsin L in IL-1β-treated cells with or without CPT was examined using Western blotting. Results: The ratio of viable cell numbers was significantly decreased by 100 μmol/l CPT. Next, the increase of IL-6 and cathepsin L induced by IL-1β was significantly suppressed by the pretreatment of 10 μmol/l CPT in HGFs. On the other hand, productivity of VEGF induced by IL-1β was not changed by the pretreatment of 10 μmol/l CPT. Conclusion: CPT suppresses IL-1β-induced IL-6 and cathepsin L production in HGFs, and might regulate the progression of periodontitis.
Jun-ichi Kido, Yukiko Bandou, Mika Bandou, Yukari Kajiura, Yuka Hiroshima, Yuji Inagaki, Hiromi Murata, Takahisa Ikuta, Reiko Kido, Koji Naruishi, Makoto Funaki and Toshihiko Nagata : YKL-40 level in gingival crevicular fluid from patients with periodontitis and type 2 diabetes, Oral Diseases, Vol.21, No.5, 667-673, 2015.
(Summary)
YKL-40 is a chitin-binding glycoprotein, the level of which increases in inflammatory diseases, diabetes mellitus (DM), cardiovascular diseases, and tumors. Gingival crevicular fluid (GCF) contains many proteins and markers of periodontitis. The purpose of this study was to investigate YKL-40 level in GCF from patients with periodontitis and DM and the association between YKL-40 level and chronic periodontitis (CP) or DM. The subjects were 121 patients with DM, CP, DM and periodontitis (DM-P), and healthy subjects (H). GCF was collected using paper strips after the sites for GCF collection were clinically evaluated for probing depth (PD), gingival index (GI), and bleeding on probing (BOP). YKL-40 in GCF was identified by Western blotting, and its level was determined by ELISA. YKL-40 was contained in GCF samples from H, DM, CP, and DM-P sites, and its levels (amount and concentration) in CP and DM-P were significantly higher than those in H and DM. GCF YKL-40 level significantly correlated with PD and GI, and its level in BOP-positive sites was significantly higher than that in BOP-negative ones. GCF YKL-40 level was elevated in periodontitis, but not DM. YKL-40 in GCF may be an inflammatory marker for periodontitis.
Yuji Inagaki, Yukiko Nakajima, Masumi Horibe, 生田 貴久, Yukari Kajiura, Koji Naruishi, Jun-ichi Kido and Toshihiko Nagata : 肥満糖尿病ラット歯周炎の歯肉組織におけるオステオポンチンの局在, Journal of the Japanese Association of Periodontology, Vol.67, No.4, 149-158, 2015.
Koji Naruishi, Akiko Kunita, Katsuyuki Kubo, Toshihiko Nagata, Shogo Takashiba and Seiji Adachi : Predictors of improved functional outcome in elderly inpatients after rehabilitation: a retrospective study., Clinical Interventions in Aging, Vol.9, 2133-2141, 2014.
(Summary)
Age and disorder of oral function may be significant predictors of improved functional capacity after rehabilitation for elderly inpatients.
Kazuhiro Omori, Yoshihisa Hanayama, Koji Naruishi, Kentaro Akiyama, Hiroshi Maeda, Fumio Otsuka and Shogo Takashiba : Gingival overgrowth caused by vitamin C deficiency associated with metabolic syndrome and severe periodontal infection: a case report., Clinical Case Reports, Vol.2, No.6, 286-295, 2014.
(Summary)
It has been suggested that vitamin C deficiency/scurvy is associated with gingival inflammatory changes; however, the disorder is very infrequently encountered in the modern era. Here, we report a case of extensive gingival overgrowth caused by vitamin C deficiency associated with metabolic syndrome and severe periodontal infection.
Tetsuo Fujita, Takefumi Satoh, L Terry Timme, Takahiro Hirayama, X Julie Zhu, Nobuyuki Kusaka, Koji Naruishi, Guang Yang, Alexei Goltsov, Jianxiang Wang, T Maria Vlachaki, S Bin Teh, E Butler Brian and C Timothy Thompson : Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models., Urologic Oncology: Seminars and Original Investigations, Vol.32, No.2, 92-100, 2014.
(Summary)
Combining AdGlipr1 (AdGLIPR1) with radiotherapy may achieve additive or synergistic tumor control in selected prostate and bladder tumors, and additional therapeutic effects may result with repeated treatment cycles.
Naoki Takizawa, Shunsuke Sawada, Naoyuki Chosa, Akira Ishisaki and Koji Naruishi : Secreted caveolin-1 enhances periodontal inflammation by targeting gingival fibroblasts., Biomedical Research, Vol.34, No.1, 1-11, 2013.
(Summary)
Caveolin-1 (Cav-1) is a membrane protein. Recently, it has been reported that secreted Cav-1 induces angiogenesis in inflammatory microenvironment. However, it is unclear that Cav-1 regulates gingival inflammation. Therefore, we investigated the Cav-1 function to periodontal cells. Expression of Cav-1 in human periodontitis tissues was examined pathologically. Secretion of Cav-1 from human gingival fibroblasts (HGFs) or human periodontal ligament cells (HPLFs) treated with IL-1 and TNF- was examined using Western blotting. Likewise, intracellular signals induced by Cav-1 were examined. Finally, we examined whether the secreted Cav-1 induces production of inflammatory mediators in HGFs using ELISA or qRT-PCR. Pathologically, high expression of Cav-1 was observed in human periodontitis tissues. Cav-1 secretion increased in both cultured HGFs and HPLFs treated with IL-1 and TNF-. Cav-1 induced phosphorylation of JNK and ERK, but not Stat3 in HGFs. Furthermore, Cav-1 increased proMMP-1 and VEGF secretion in HGFs, and the VEGF secretion was statistically suppressed by JNK inhibitor SP600125, but not ERK inhibitor PD98059. ProMMP-1 secretion was suppressed statistically by both SP600125 and PD98059. In addition, Cav-1 increased significantly MMP-1, -10 and -14 mRNA expressions, whereas no increase of TIMPs mRNA was observed in HGFs treated with Cav-1. These data suggest that secreted Cav-1 derived from periodontal fibroblastic cells enhances inflammation-related several proteases and VEGF secretion in HGFs via MAPKs pathway, resulting in progression of periodontitis through induction of tissue degradation or angiogenesis.
Shunsuke Sawada, Naoyuki Chosa, Akira Ishisaki and Koji Naruishi : Enhancement of gingival inflammation induced by synergism of IL-1 and IL-6., Biomedical Research, Vol.34, No.1, 31-40, 2013.
(Summary)
Internleukin-1 (IL-1) and IL-6 are the most potent proinflammatory cytokines being involved in inflammatory diseases such as periodontitis. The objective of this study was to examine the synergistic effects of IL-1 and IL-6 on gingival inflammation by targeting cultured human gingival fibroblasts (HGFs). HGFs were treated with IL-1 or IL-6/soluble IL-6R (sIL-6R), and total RNA and total cell lysate were collected to examine expression of gp130 known as a signal transducer of IL-6 using qRT-PCR and Western blotting. IL-1-mediated IL-6 productivity in HGFs was examined using ELISA method. Likewise, after HGFs and THP-1 macrophages were treated with IL-1, TNF- and IL-6, sIL-6R productivity was examined. Next, HGFs were treated with IL-6/ sIL-6R after pretreatment of IL-1, and the intracellular signals were examined using Western blotting. Finally, various mRNA/protein expressions in HGFs treated with IL-6/sIL-6R after pretreatment of IL-1 were examined using qRT-PCR and ELISA method. IL-1 increased significantly both gp130 and IL-6 expression in HGFs. IL-6 increased significantly sIL-6R production in THP-1 macrophages but not HGFs. Co-stimulation with IL-1 and IL-6/sIL-6R induced dramatically the phosphorylation of Stat3, ERK and JNK in HGFs. Interestingly, expression of various inflammation- related molecules such as MMP-1, MCP-1, IL-1ra, bFGF and VEGF were enhanced by co-stimulation with IL-1 and IL-6/sIL-6R in HGFs. Gingival inflammation is regulated by HGFs affected by both IL-1 and IL-6/sIL-6R synergistically through induction of gp130 expression, resulting in progression of periodontitis.
C Kudo, Koji Naruishi, H Maeda, Y Abiko, T Hino, M Iwata, C Mitsuhashi, S Murakami, T Nagasawa, Toshihiko Nagata, Satoshi Yoneda, Y Nomura, T Noguchi, Y Numabe, Y Ogata, T Sato, H Shimauchi, K Yamazaki, A Yoshimura and S Takashiba : Assessment of the plasma/serum IgG test to screen for periodontitis., Journal of Dental Research, Vol.91, No.12, 1190-1195, 2012.
(Summary)
Chronic periodontitis is a silent infectious disease prevalent worldwide and affects lifestyle-related diseases. Therefore, efficient screening of patients is essential for general health. This study was performed to evaluate prospectively the diagnostic utility of a blood IgG antibody titer test against periodontal pathogens. Oral examination was performed, and IgG titers against periodontal pathogens were measured by ELISA in 1,387 individuals. The cut-off value of the IgG titer was determined in receiver operating characteristic curve analysis, and changes in periodontal clinical parameters and IgG titers by periodontal treatment were evaluated. The relationships between IgG titers and severity of periodontitis were analyzed. The best cut-off value of IgG titer against Porphyromonas gingivalis for screening periodontitis was 1.682. Both clinical parameters and IgG titers decreased significantly under periodontal treatment. IgG titers of periodontitis patients were significantly higher than those of healthy controls, especially in those with sites of probing pocket depth over 4 mm. Multiplied cut-off values were useful to select patients with severe periodontitis. A blood IgG antibody titer test for Porphyromonas gingivalis is useful to screen hitherto chronic periodontitis patients.
Tamaki Takahashi, Shigeo Muro, Naoya Tanabe, Kunihiko Terada, Hirofumi Kiyokawa, Susumu Sato, Yuma Hoshino, Emiko Ogawa, Kazuko Uno, Koji Naruishi, Shogo Takashiba and Michiaki Mishima : Relationship between periodontitis-related antibody and frequent exacerbations in chronic obstructive pulmonary disease., PLoS ONE, Vol.7, No.7, e40570, 2012.
(Summary)
Normal-IgG titer for periodontitis-related antibody can be an independent predictor of frequent exacerbations. Measuring periodontitis-related antibody titers might be useful to identify patients with susceptibility to frequent exacerbations so that an aggressive prevention strategy can be designed.
Shinya Tsuge, Yasuyoshi Mizutani, Kazuhiro Matsuoka, Tatsuya Sawasaki, Yaeta Endo, Koji Naruishi, Hiroshi Maeda, Shogo Takashiba, Kazuya Shiogama, Ken-Ichi Inada and Yutaka Tsutsumi : Specific in situ visualization of plasma cells producing antibodies against Porphyromonas gingivalis in gingival radicular cyst: application of the enzyme-labeled antigen method., The Journal of Histochemistry and Cytochemistry, Vol.59, No.7, 673-689, 2011.
(Summary)
The enzyme-labeled antigen method was applied to visualize plasma cells producing antibodies to Porphyromonas gingivalis, flora of the human oral cavity. Antibodies to P. gingivalis have reportedly been detected in sera of patients with periodontitis. Biotinylated bacterial antigens, Ag53, and four gingipain domains (Arg-pro, Arg-hgp, Lys-pro, and Lys-hgp) were prepared by the cell-free protein synthesis system using the wheat germ extract. In paraformaldehyde-fixed frozen sections of rat lymph nodes experimentally immunized with Ag53-positive and Ag53-negative P. gingivalis, plasma cells were labeled with biotinylated Arg-hgp and Lys-hgp. Antibodies to Ag53 were detected only in the nodes immunized with Ag53-positive bacteria. In two of eight lesions of gingival radicular cyst with inflammatory infiltration, CD138-positive plasma cells in frozen sections were signalized for Arg-hgp and Lys-hgp. An absorption study using unlabeled antigens confirmed the specificity of staining. The AlphaScreen method identified the same-type antibodies in tissue extracts but not in sera. Antibodies to Ag53, Arg-pro, and Lys-pro were undetectable. In two cases, serum antibodies to Arg-hgp and Lys-hgp were AlphaScreen positive, whereas plasma cells were scarcely observed within the lesions. These findings indicate the validity of the enzyme-labeled antigen method. This is the very first application of this novel histochemical technique to human clinical samples.
Koji Naruishi, K Omori, H Maeda, N Sonoi, K Funakoshi, K Hirai, M Ishii, K Kubo, H Kobayashi, T Tomiyama, D Yamamoto, I Tanimoto, K Kunimatsu and S Takashiba : Immune responses to porphyromonas gingivalis infection suppress systemic inflammatory response in experimental murine model., Journal of Biological Regulators and Homeostatic Agents, Vol.25, No.2, 195-202, 2011.
(Summary)
Periodontitis is a localized infectious disease caused by periodontopathic bacteria such as Porphyromonas gingivalis (P. gingivalis), and the severity correlates to significance of immune responses. Recently, it has been reported that periodontitis is associated with the development of systemic disease such as diabetes and atherosclerosis because of increasing invasion of oral pathogens to the circulation. However, the association between local and systemic infectious responses is still unclear. In the present study, we examined the differences of biological responses in animals with or without bacterial infection. After Balb/c mice were infected subcutaneously with live P. gingivalis W83, serum, skin and liver were collected according to experimental protocol. The skin and liver tissues were observed pathologically by haematoxylin-eosin staining, and serum IL-6 levels were measured using ELISA method. Throughout the experimental period, conditions of the mice were observed continuously. As expected, severe infiltration of leukocytes were observed at inflamed skin corresponding to the number of bacterial challenges. Although no inflammatory appearance of skin was observed, serum IL-6 levels were increased dramatically (P <0.01, Student's t-test) and liver tissues were injured in the mice without bacterial challenge. Interestingly, although severe inflammatory appearance of the skin was observed, serum IL-6 levels were not increased and no inflammatory responses were observed in the liver of the 3-times bacterially challenged group. Importantly, immunoglobulin G against P. gingivalis W83 was detected in the blood of mice with 3-times bacterial challenge corresponding to improvement of weight loss and survival. In conclusion, although multiple infections develop severe localized inflammation, the immune system should be sufficient to protect the systemic inflammatory responses.
村井 治, Koji Naruishi, 佐々木 大輔, 大川 義人, 八重柏 隆 and 國松 和司 : 臨床研究 医科歯科連携医療における歯周病原細菌に対する血清IgG抗体価検査の導入, Journal of Japanese Society for Evidence and the Dental Professional, Vol.3, No.1, 36-41, 2011.
Noriko Sugi, Koji Naruishi, Chieko Kudo, Aya Hisaeda-Kako, Takayuki Kono, Hiroshi Maeda and Shogo Takashiba : Prognosis of periodontitis recurrence after intensive periodontal treatment using examination of serum IgG antibody titer against periodontal bacteria., Journal of Clinical Laboratory Analysis, Vol.25, No.1, 25-32, 2011.
(Summary)
Chronic periodontitis is associated with systemic diseases such as atherosclerosis. In this study, we evaluated the efficacy of serum IgG antibody titer to periodontal bacteria for prognosis of periodontitis recurrence during supportive periodontal therapy (SPT) phase. The 139 patients during SPT phase were selected and divided to two groups as follows: "Stable" and "Recurrence" group at SPT phase for case-control study: "High IgG titer" and "Normal IgG titer" group before transition to SPT phase for cohort study. We examined whether clinical findings or serum IgG antibody titers to periodontal bacteria are risk factors for the development of periodontitis recurrence. Case-control study showed that there were significant differences between the stable and recurrence groups in age and number of teeth. The serum IgG antibody titer to Eikenella corrodens FDC1073, Porphyromonas gingivalis SU63, and Campylobacter rectus ATCC33238 was significantly higher in the recurrence group. Next, we found, that the recurrence ratio in the high IgG titer group to Gram-negative obligate anaerobe, Prevotella intermedia, Treponema denticola, and C. rectus was significantly higher than that of the normal IgG titer group. Taken together, serum IgG antibody titer test is useful in the prognosis of periodontitis recurrence during the SPT phase.
Osamu Murai, Koji Naruishi, Satoshi Ogihara, Nagisa Suwa, Satomi Kanazawa, Takashi Yaegashi, Yasunori Takeda and Kazushi Kunimatsu : Cathepsin B, D, and L regulation in cyclosporin A-mediated gingival hyperplasia of a patient with sarcoidosis., Clinical Laboratory, Vol.57, No.7-8, 535-541, 2011.
(Summary)
Cyclosporin A (CsA) is an immunosuppressant with side effects including gingival hyperplasia. Sarcoidosis is a systemic disease characterized by granulomas. Here, we report on a rare case of sarcoidosis with gingival hyperplasia to clarify whether clinical observation corresponds to in vitro results. Gingival fibroblasts (HGFs) were isolated from healthy gingiva and cultured with CsA. Total RNA was collected and expression of mRNAs examined using semi-quantitative RT-PCR analysis. Cathepsin B, D, and L expression in overgrown gingiva of the patient was examined by immunohistochemistry. Cathepsin D, L, and vascular endothelial growth factor (VEGF)165 mRNA were markedly suppressed in CsA-treated HGFs, whereas cathepsin B, matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) mRNA were not reduced. Next, the decrease of cathepsin B and L expression in enlarged gingiva was observed, whereas an increase of cathepsin D expression was observed. Clinically, the enlarged gingival lesions were fully resolved by performing oral infection control. Cathepsins regulation might be an important factor in the development of CsA-mediated gingival hyperplasia.
Junya INUBUSHI, Kazu HATANAKA, Takako YASUDA, Koji Naruishi, Hidehiko OOTSUKI and Shogo TAKASHIBA : Clinical and microbiological effect of newly developed OTC periodontal ointment-containing applicator with brush on the SPT phase, Journal of the Japanese Association of Periodontology, Vol.52, No.3, 225-238, 2010.
(Summary)
It is important for maintaining improved periodontal tissue health during supportive periodontal therapy (SPT) to restrain infection caused by periodontopathic bacteria by the patients' own self control in addition to periodic professional intervention. We developed an over-the-counter (OTC) medication, named MC1, consisting of a one-tuft brush containing the compound cetylpyridinium chloride (CPC) as a bactericidal agent, dipotassium glycyrrhizate (GK2) as an anti-inflammatory drug, and allantoin (ALT) as a promoter of cell proliferation and wound healing, for delivery to hardly-brushed regions. In this study, we evaluated the effectiveness of MC1 clinically and microbiologically in maintaining improved periodontal tissue status during SPT.<BR>This study was designed as a double-blind clinical trial targeting chronic periodontitis patients during the SPT phase. Sixty-one subjects (test group: 27 subjects, placebo group: 28 subjects, dropout: 6 subjects) participated in this study, and applied MC1 to 2 molar periodontal pockets 4mm twice a day for 12 weeks. The clinical indicators used were the probing pocket depth (PPD), bleeding on probing (BOP), plaque control record (PCR), gingival index (GI), and weight of the gingival crevicular fluid (GCF). The microbiological indicators were the number of total bacteria, <I>Porphyromonas gingivalis</I>, <I>Tannerella forsythia</I>, and <I>Treponema denticola</I>. These were evaluated at the baseline, and at the 6- and 12-week time-points.<BR>All of the clinical indicators other than PCR were significantly improved in both groups in a time-dependent manner, and earlier improvement tended to be noted in the test group with GI and GCF volume than in the placebo group. On the other hand, the numbers of all of the examined bacteria at sites with a PPD 5mm were significantly improved in the test group as compared with those in the placebo group.<BR>It is suggested that MC1 is effective in maintaining the state of the periodontal tissue clinically and microbiologically in chronic periodontitis patients during the SPT phase.<BR>Nihon Shishubyo Gakkai Kaishi(J Jpn Soc Periodontol)52(3) : 225-238, 2010.
K Yamabe, H Maeda, S Kokeguchi, Y Soga, M Meguro, Koji Naruishi, S Asakawa and S Takashiba : Antigenic group II chaperonin in Methanobrevibacter oralis may cross-react with human chaperonin CCT., Molecular Oral Microbiology, Vol.25, No.2, 112-122, 2010.
(Summary)
Methanobrevibacter oralis is an archaeal species frequently isolated from sites of severe periodontitis. However, its pathogenic roles remain unclear. Here, we aimed to isolate group II chaperonin from M. oralis and examine its antigenicity. The genes encoding two chaperonin subunits (Cpn-1 and Cpn-2) were cloned from M. oralis using polymerase chain reaction and genome walking procedures. Recombinant proteins Cpn-1 and Cpn-2 were generated, and the reactivities of sera from patients with periodontitis were examined by Western immunoblotting. The open reading frames of Cpn-1 and Cpn-2 genes consisted of 1641 and 1614 base pairs, respectively. Putative ATP-binding domains conserved among the chaperonin family were observed in both genes. The deduced amino acid sequences of the two genes showed 28.8-40.0% identity to each of the subunits of human CCT (CCT1-8). Thirty and 29 of 36 patients' sera reacted with the recombinant Cpn-1 and recombinant Cpn-2, respectively. Western immunoblotting using antiserum against human CCT subunits indicated that anti-CCT3 and anti-CCT8 antibodies recognized recombinant Cpn-1. In addition, anti-CCT1, CCT3, CCT6, and CCT8 antibodies recognized an antigen of approximately 60 kDa in M. oralis. The results suggested that the chaperonin subunits of M. oralis were antigenic molecules that were recognized by periodontitis patients and that may cross-react with human chaperonin CCT.
Y Koide, H Maeda, K Yamabe, Koji Naruishi, T Yamamoto, S Kokeguchi and S Takashiba : Rapid detection of mecA and spa by the loop-mediated isothermal amplification (LAMP) method., Letters in Applied Microbiology, Vol.50, No.4, 386-392, 2010.
(Summary)
The LAMP offers an alternative detection assay for mecA and spa with a great advantage of the rapidity.
(Keyword)
Aged / Aged, 80 and over / Bacterial Proteins / Bacteriological Techniques / DNA, Bacterial / Dental Plaque / Humans / Limit of Detection / Methicillin-Resistant Staphylococcus aureus / Middle Aged / Nucleic Acid Amplification Techniques / Polymerase Chain Reaction / Sensitivity and Specificity / Staphylococcal Protein A
小出 康史, 杉 典子, 向井 麻理子, 児玉 由佳, 竹本 奈奈, 大隅 満奈, 藤井 友利江, Koji Naruishi and 高柴 正悟 : 臨床研究 周術期患者に対する口腔管理システムの樹立と評価, Journal of Japanese Society for Evidence and the Dental Professional, Vol.2, No.1, 45-49, 2010.
Takemasa Maeda, Hiroshi Maeda, Kokoro Yamabe, Junji Mineshiba, Ichiro Tanimoto, Tadashi Yamamoto, Koji Naruishi, Susumu Kokeguchi and Shogo Takashiba : Highly expressed genes in a rough-colony-forming phenotype of Aggregatibacter actinomycetemcomitans: implication of a mip-like gene for the invasion of host tissue., FEMS Immunology and Medical Microbiology, Vol.58, No.2, 226-236, 2009.
(Summary)
Aggregatibacter actinomycetemcomitans, a potent pathogen of periodontitis, typically grows as a rough and adherent colony on primary isolated cultures. The colony transforms into a smooth phenotype during repeated subculture. In this study, we aimed to identify highly expressed genes in the rough-colony-forming phenotype for isolation of host-induced genes. Using a cDNA-subtractive hybridization technique, three genes, homologous to a macrophage infectivity potentiator gene (mip), peroxiredoxin gene (prx) and outer membrane protein gene (ompA), were identified. The expression levels of these genes in the rough-colony-forming phenotype were 4-10-fold higher as compared with the smooth-colony-forming phenotype. Attention was focused on the mip-like gene, and a recombinant protein and a deficient mutant were constructed. The recombinant protein reacted with sera from patients with periodontitis, suggesting the production of the Mip-like protein in periodontal lesions. Viable quantitative invasion assay demonstrated that the viable cell counts of the wild-type strain that invaded HeLa cells were more than fourfold as compared with the mip-deficient mutant. The expression of the mip-like gene, prx-like gene and ompA-like gene may be enhanced in the host, and the mip-like gene may play an important role in the infection of A. actinomycetemcomitans, especially in its invasion of the epithelium.
Masami Watanabe, Guang Yang, Guangwen Cao, A Salahaldin Tahir, Koji Naruishi, Ken-Ichi Tabata, Abdel Elmoataz Fattah, Kartik Rajagopalan, L Terry Timme, Sanghee Park, Shinji Kurosaka, Kohei Edamura, Ryuta Tanimoto, J Francesco Demayo, A Alexei Goltsov and C Timothy Thompson : Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression., Molecular Cancer Research : MCR, Vol.7, No.9, 1446-1455, 2009.
(Summary)
Previously, we reported that caveolin-1 (cav-1) is overexpressed in metastatic prostate cancer and that virulent prostate cancer cells secrete biologically active cav-1. We also showed that cav-1 expression leads to prosurvival activities through maintenance of activated Akt and that cav-1 is taken up by other cav-1-negative tumor cells and/or endothelial cells, leading to stimulation of angiogenic activities through PI-3-K-Akt-eNOS signaling. To analyze the functional consequences of cav-1 overexpression on the development and progression of prostate cancer in vivo, we generated PBcav-1 transgenic mice. Adult male PBcav-1 mice showed significantly increased prostatic wet weight and higher incidence of epithelial hyperplasia compared with nontransgenic littermates. Increased immunostaining for cav-1, proliferative cell nuclear antigen, P-Akt, and reduced nuclear p27(Kip1) staining occurred in PBcav-1 hyperplastic prostatic lesions. PBcav-1 mice showed increased resistance to castration-induced prostatic regression and elevated serum cav-1 levels compared with nontransgenic littermates. Intraprostatic injection of androgen-sensitive, cav-1-secreting RM-9 mouse prostate cancer cells resulted in tumors that were larger in PBcav-1 mice than in nontransgenic littermates (P = 0.04). Tail vein inoculation of RM-9 cells produced significantly more experimental lung metastases in PBcav-1 males than in nontransgenic male littermates (P = 0.001), and in cav-1(+/+) mice than in cav-1(-/-) mice (P = 0.041). Combination treatment with surgical castration and systemic cav-1 antibody dramatically reduced the number of experimental metastases. These experimental data suggest a causal association of secreted cav-1 and prostate cancer growth and progression.
工藤 値英子, Koji Naruishi, 久松 綾, 新井 英雄, 前田 博史 and 高柴 正悟 : 歯周病スクリーニング検査としての歯周病原細菌に対する指尖血漿IgG抗体価の有用性, Journal of Japanese Society for Evidence and the Dental Professional, Vol.1, No.1, 13-19, 2009.
(Keyword)
periodontal disease / screening test / serum (plasma) IgG antibody titer / ELISA / mail testing
K Tabata, M Watanabe, Koji Naruishi, K Edamura, T Satoh, G Yang, E Fattah Abdel, J Wang, A Goltsov, D Floryk, D S Soni, D Kadmon and C T Thompson : Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer., Prostate Cancer and Prostatic Diseases, Vol.12, No.3, 301-309, 2008.
(Summary)
We evaluated the potential use of intraoperative gelatin matrix hemostatic sealant (GMHS; FloSeal; Baxter Healthcare) embedded with macrophages (Mphi) transduced with murine interleukin (IL)-12 recombinant adenoviral vector (G/Mphi/AdmIL-12) for prevention of recurrence of prostate cancer following radical prostatectomy. Application of G/Mphi/AdmIL-12 resulted in significant suppression of tumor growth and spontaneous lung metastases, a statistically significant survival advantage of the G/Mphi/AdmIL-12-treated animals, more efficient trafficking of Mphi to lymph nodes draining from the prostate and generation of systemic natural killer cell activity and tumor-specific cytolytic T lymphocyte responses compared to the controls in a preclinical mouse model of residual prostate cancer. Our data recommend this treatment as a novel adjuvant for prevention of local recurrence of prostate cancer following radical prostatectomy.
Tomoko Yamaguchi, Koji Naruishi, Hideo Arai, Fusanori Nishimura and Shogo Takashiba : IL-6/sIL-6R enhances cathepsin B and L production via caveolin-1-mediated JNK-AP-1 pathway in human gingival fibroblasts., Journal of Cellular Physiology, Vol.217, No.2, 423-432, 2008.
(Summary)
Interleukin (IL)-6 has an important role in inflammatory diseases. Lysosomal enzymes cathepsins are widely expressed as cysteine proteases regulating inflammatory process. Caveolin-1 (Cav-1) is a scaffolding/regulatory membrane protein that interacts with signaling molecules. In this study, we investigated the role of Cav-1 on (1) the productivity, and (2) the enzymatic activity of cathepsin B and L in human gingival fibroblasts (HGFs) treated with IL-6 in the presence of soluble form of IL-6 receptor (sIL-6R). At first, we established the siRNA-mediated Cav-1 down-regulating in vitro systems by transient transfection of Cav-1 siRNA. The siRNA-mediated Cav-1 down-regulated cells were treated with IL-6/sIL-6R for indicated times. Then, cell lysates were collected, and examined the IL-6-induced signaling pathway, cathepsin B and L production, and measurement of cathepsins activity. To investigate the cathepsin L activity, cathepsin-(B + L) activity was measured after pretreatment with CA-074Me, a specific inhibitor for cathepsin B. We found that IL-6/sIL-6R enhanced significantly both production and activity of cathepsin B and L in HGFs. Interestingly, IL-6-mediated phosphorylation of both p44/42 MAPK and JNK was dramatically suppressed in Cav-1 down-regulated HGFs treated with IL-6/sIL-6R. In addition, both production and activity of cathepsin B and L were also significantly suppressed. Importantly, we demonstrated that JNK inhibition, but not p44/42 MAPK inhibition, significantly diminished IL-6/sIL-6R-induced cathepsin B and L production. Taken together, we concluded that IL-6/sIL-6R enhances cathepsin B and L production via IL-6/sIL-6R-mediated Cav-1-JNK-AP-1 pathway in HGFs. Our findings indicate that Cav-1 might be a therapeutic target for IL-6-mediated tissue degradation in periodontitis.
(Keyword)
Anthracenes / Cathepsin B / Cathepsin L / Cathepsins / Caveolin 1 / Cells, Cultured / Cysteine Endopeptidases / Dipeptides / Fibroblasts / flavonoids / Gingiva / Humans / Interleukin-6 / JNK Mitogen-Activated Protein Kinases / Mitogen-Activated Protein Kinase 1 / Mitogen-Activated Protein Kinase 3 / periodontitis / phosphorylation / Protease Inhibitors / Protein Kinase Inhibitors / RNA Interference / RNA, Small Interfering / Receptors, Interleukin-6 / Recombinant Proteins / signal transduction / Time Factors / Transcription Factor AP-1 / Transfection / Up-Regulation
福家 教子, 苅田 典子, 熊崎 洋平, Koji Naruishi, 大西 典子, 明貝 文夫, 岩本 義博, 新井 英雄 and 高柴 正悟 : サポーティブペリオドンタルセラピーによる歯周炎の再発防止と進行抑制の効果に関する統計学的検討, The Journal of Okayama Dental Society, Vol.27, No.2, 105-113, 2008.
58.
Guang Yang, L Terry Timme, Koji Naruishi, Tetsuo Fujita, Abdel El Moataz Fattah, Guangwen Cao, Kartik Rajagopalan, Kartik Rajocopolan, D Luan Troung and C Timothy Thompson : Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation., Experimental and Molecular Pathology, Vol.84, No.2, 131-140, 2007.
(Summary)
Caveolin-1 (cav-1) is a major structural protein of caveolae, small invaginations of the plasma membrane that integrate and regulate signaling pathways involved in cell growth and differentiation. We previously generated a genetically engineered mice that are homozygous for a null mutation in exon 2 of cav-1 and documented increased incidence of urolithiasis in young male cav-1(-/-) mice. We attributed this, in part, to improper localization of plasma membrane calcium/calmodulin-dependent calcium ATPase in the distal convoluted tubules of the kidney. To document pathologies related to cav-1 function, we maintained cav-1(-/-) and control cav-1(+/+) mice for an extended time period. We report here that cav-1(-/-) mice demonstrate organ-specific growth-related disorders in stromal cells that normally have high levels of cav-1 expression. In many of these organs, epithelial cell growth/differentiation abnormalities were also observed, yet in most of these sites the epithelial cells normally express low to non-detectable levels of cav-1. We propose that loss of cav-1 function in stromal cells of various organs directly leads to a disorganized stromal compartment that, in turn, indirectly promotes abnormal growth and differentiation of adjacent epithelium.
Kazuhiro Omori, Koji Naruishi, Tomoko Yamaguchi, Shun-Ai Li, Mayumi Yamaguchi-Morimoto, Kaori Matsuura, Hideo Arai, Kohji Takei and Shogo Takashiba : cAMP-response element binding protein (CREB) regulates cyclosporine-A-mediated down-regulation of cathepsin B and L synthesis., Cell and Tissue Research, Vol.330, No.1, 75-82, 2007.
(Summary)
Cyclosporin A (CsA) is an immunosuppressant with severe side effects including gingival overgrowth. We have previously reported that CsA impairs the activity of the lysosomal enzymes cathepsin B and L in human gingival fibroblasts (HGFs). Here, we have examined the effects of CsA on the DNA-binding activity of the cyclic AMP response element-binding protein (CREB) and cell viability, and the effects of CREB on cathepsin B and L synthesis and activity in HGFs. We have confirmed that CsA down-regulates cathepsin B and L synthesis. Further, CsA has no effect on cell viability and dramatically impairs CREB-DNA binding activity. Importantly, the synthesis of cathepsin B and L is down-regulated, and their activity is also significantly impaired in HGFs transfected with plasmid expressing dominant-negative CREB. These results suggest that CREB is essential for the CsA-mediated down-regulation of cathepsin B and L synthesis in HGFs.
H Wang, G Yang, L T Timme, T Fujita, Koji Naruishi, A Frolov, K M Brenner, D Kadmon and C T Thompson : IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer., Cancer Gene Therapy, Vol.14, No.10, 819-827, 2007.
(Summary)
To investigate the immunomodulatory effects of interleukin-12 (IL-12) for treatment of metastatic prostate cancer, we administered adult bone marrow cells (BMC) that were genetically modified by retroviral vector-mediated IL-12 gene transduction in an experimental mouse model of prostate cancer metastasis. This therapy produced significant anti-metastatic effects in bone and lung and prolonged animal survival. Flow cytometric analysis indicated donor BMC could effectively home to bone and lung after treatment. Intensive infiltration of CD4 and CD8T cells in lung metastases and increased systemic natural killer and cytotoxic T lymphocyte activities indicated induction of a significant anti-metastatic immune response after treatment with IL-12 transduced BMC. Our results demonstrate the therapeutic potential of gene-modified BMC gene therapy.
Arias Zulema Rosalia Martinez, Koji Naruishi, Keisuke Yamashiro, Fumio Myokai, Teruo Yamada, Kaori Matsuura, Naoko Namba, Hideo Arai, Junzo Sasaki, Yoshimitsu Abiko and Shogo Takashiba : Gene profiles during root canal treatment in experimental rat periapical lesions., Journal of Endodontics, Vol.33, No.8, 936-943, 2007.
(Summary)
The purpose of this study was to profile gene expression in periapical lesions during root canal treatment (RCT). Periapical lesions were induced experimentally by exposing the pulp in Sprague-Dawley rats. After 3 wk, the animals received root canal filling (RCF) and were sacrificed 1 or 4 wk later. From the periapical tissues, total RNA was extracted and processed for cDNA-microarray analysis. The lesions were histologically and radiographically confirmed to expand 4 wk after pulp exposure (inflammation phase) and to stabilize 4 wk after RCF (healing phase). In approximately 30,000 genes on the microarray, 203 genes were up-regulated to more than 5-fold (e.g., IL-1beta), and 864 genes were down-regulated to less than 20% of baseline level (e.g., caspase 8) in inflammation phase. Compared with inflammation phase, we found that 133 genes were up-regulated (e.g., IL-1alpha) and 50 genes were down-regulated (e.g., defensin alpha5) in healing phase. Corresponding to the gene expression profiles, accumulation of IL-1alpha and IL-1beta was observed in the periapical lesions by immunohistochemistry. These gene profiles might be useful in diagnosing the healing process of periapical lesions.
T Fujita, L T Timme, K Tabata, Koji Naruishi, N Kusaka, M Watanabe, E Abdelfattah, X J Zhu, C Ren, C Ren, G Yang, A Goltsov, H Wang, T M Vlachaki, S B Teh, B E Butler and C T Thompson : Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer., Gene Therapy, Vol.14, No.3, 227-236, 2006.
(Summary)
We investigated the potential benefits of combining adenoviral vector mediated in situ interleukin-12 (AdmIL-12) gene therapy with radiation therapy (XRT) to enhance therapeutic efficacy. In a metastatic mouse prostate cancer cell line, 178-2 BMA, AdmIL-12+XRT demonstrated enhanced therapeutic activities in vitro as determined by clonogenic survival, apoptosis, and mIL-12 levels. At the molecular level, increased expression of tumor necrosis factor-alpha mRNA was specific for the combined therapy. In a subcutaneous 178-2 BMA in vivo model, the combination of AdmIL-12+XRT produced statistically significant tumor growth suppression compared to control vector Adbetagal, Adbetagal XRT, or AdmIL-12 as monotherapy. In addition, significant prolongation of survival was demonstrated for the combination of AdmIL-12+XRT. The combination of AdmIL-12+XRT significantly suppressed both spontaneous and pre-established lung metastases, and led to a prolonged elevation of serum IL-12 and significantly increased natural killer (NK) activities. Importantly, in vivo depletion of NK cells resulted in significant attenuation of the antimetastatic activities of AdmIL-12 alone or AdmIL-12+XRT. These combined effects suggest that AdIL-12 gene therapy together with radiotherapy may achieve maximal tumor control (both local and systemic) in selected prostate cancer patients via radio-gene therapy induced local cytotoxicity and local and systemic antitumor immunity.
Nobuyuki Shiomi, Fumio Myokai, Koji Naruishi, Kosuke Oyaizu, Kyoko Senoo, Tomoko Yamaguchi, Salomon Amar and Shogo Takashiba : Cloning and characterization of lipopolysaccharide-induced tumor necrosis factor alpha factor promoter., FEMS Immunology and Medical Microbiology, Vol.47, No.3, 360-368, 2006.
(Summary)
We have recently identified lipopolysaccharide tumor-induced tumor necrosis factor alpha factor (LITAF) as a novel transcription factor controlling necrosis factor (TNF)-alpha expression in the human monocytic cell line, THP-1. To characterize the human (h) LITAF promoter, we isolated a 1.2-kb DNA fragment and followed this by a screening of human genomic DNA with a hLITAF cDNA probe. A 34-bp sequence domain located from nucleotides -74 to -43 in the hLITAF promoter exhibited the highest basal reporter gene activity; however, the activity was not elevated by lipopolysaccharide (LPS) stimulation. The sequence domain included a consensus sequence for hepatocyte nuclear factor (HNF)-3alpha, regulating the transcription of many kinds of genes. Interestingly, the DNA sequence position between -542 and -538 in the hLITAF promoter contained the CTCCC motif, which has been reported to act as a specific binding site for hLITAF protein. Electrophoretic mobility shift assays demonstrated that LPS induced the binding of THP-1 nuclear factors to a 22 bp probe containing the CTCCC motif. In addition, hLITAF mRNA and nuclear hLITAF protein increased significantly in the THP-1 cells immediately after LPS stimulation. These results suggest that the consensus sequence for HNF-3alpha, or a nuclear binding protein to the CTCCC motif, may play an important role in regulating LPS-dependent LITAF transcription.
Koji Naruishi, L T Timme, N Kusaka, T Fujita, G Yang, A Goltsov, T Satoh, X Ji, W Tian, E Abdelfattah, T Men, M Watanabe, K Tabata and C T Thompson : Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer., Cancer Gene Therapy, Vol.13, No.7, 658-663, 2006.
(Summary)
We previously identified a novel p53 target gene, RTVP-1, that possesses unique cytotoxic and immunostimulatory activities which make it potentially useful for cancer gene therapy. To test the therapeutic potential of RTVP-1 in a gene-modified tumor cell-based vaccine model, we used an adenoviral vector capable of efficient transduction and expression of RTVP-1 (AdRTVP-1), together with a highly metastatic mouse prostate cancer cell line (178-2 BMA). A vaccine was prepared with 178-2 BMA cells transduced with AdRTVP-1 or a control adenoviral vector expressing beta-galactosidase (Adbetagal). After irradiation of the cells, syngeneic 129/Sv mice were vaccinated three times at weekly intervals. After 3 weeks, they were challenged with orthotopic 178-2 BMA cells. After 21 days, fewer than 60% of the RTVP-1-cell-vaccinated mice developed tumors compared to 100% of the control mice. The RTVP-1-cell vaccine significantly reduced primary tumor wet weight compared with control Adbetagal-cell vaccine (P<0.0001 at 7 and 14 days). Experimental metastasis to lung was also significantly reduced (P=0.0377), and survival significantly increased (P=0.0002). In addition, significantly increased NK and CTL activities were demonstrated in the AdRTVP-1-cell-vaccinated mice. These findings indicate that RTVP-1 gene-modified cell-based vaccines may be useful in the prevention of recurrent prostate cancer.
Tetsuo Fujita, S Bin Teh, L Terry Timme, Wei-Yuan Mai, Takefumi Satoh, Nobuyuki Kusaka, Koji Naruishi, Abdel Elmoataz Fattah, Estuardo Aguilar-Cordova, Brian E Butler and C Timothy Thompson : Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients., International Journal of Radiation Oncology*Biology*Physics, Vol.65, No.1, 84-90, 2006.
(Summary)
Sustained long-term (up to 8 to 12 months) systemic T-cell responses were noted after combined radio-gene-hormonal therapy for prostate cancer. Prolonged use of hormonal therapy does not suppress this response. These results suggest the potential for sustained activation of cell-mediated immune responses against cancer.
Mayumi Yamaguchi, Koji Naruishi, Hisa Yamada-Naruishi, Kazuhiro Omori, Fusanori Nishimura and Shogo Takashiba : Long-term cyclosporin A exposure suppresses cathepsin-B and -L activity in gingival fibroblasts., Journal of Periodontal Research, Vol.39, No.5, 320-326, 2004.
(Summary)
The decreased ability of protein degradation by not only cathepsin-L but also cathepsin-B is, at least, one of the several factors developing the cyclosporin A-induced gingival overgrowth.
Milan Petelin, Koji Naruishi, Nobuyuki Shiomi, Junji Mineshiba, Hideo Arai, Fusanori Nishimura, Shogo Takashiba and Yoji Murayama : Systemic up-regulation of sTNFR2 and IL-6 in Porphyromonas gingivalis pneumonia in mice., Experimental and Molecular Pathology, Vol.76, No.1, 76-81, 2004.
(Summary)
Aspiration pneumonia is a common cause of death in older people, and the pathophysiology is a chronic respiratory failure with a mild airway inflammation. In this study, we established a mild inflammatory pneumonia model using Porphyromonas gingivalis (Pg) pathogen-infected mice. It elucidated the effects of Pg-infected pneumonia on proinflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin-6 (IL-6), and IL-1beta production in both lung tissue and serum. We also elucidated production of soluble (s) TNF receptor (R) s, because TNF-alpha is considered to be a dominant inflammatory mediator. Lung TNF-alpha levels significantly increased at 2 h after infection, and rapidly returned to basal level at 24 h. Consistent with increase of TNF-alpha, remarkable increase of sTNFR2 but not sTNFR1 was detected in lung tissue from 2 to 72 h. Interestingly, sTNFR2/sTNFR1 ratio was significantly enhanced at 2 h in serum. In addition, lung IL-1beta and IL-6 levels also significantly increased from 2 to 24 h. Importantly, we found that IL-6 levels in serum reflected its local level. These results may suggest that systemically produced sTNFR2 and IL-6 could be a key role to modulate proinflammatory activities of TNF-alpha in Pg-induced lung inflammation simulated aspiration pneumonia.
(Keyword)
Animals / Antigens, CD / Bacteroidaceae Infections / Disease Models, Animal / Enzyme-Linked Immunosorbent Assay / Interleukin-1 / Interleukin-6 / Lung / Male / Mice / Mice, Nude / Pneumonia, Aspiration / Porphyromonas gingivalis / Receptors, Tumor Necrosis Factor / Receptors, Tumor Necrosis Factor, Type I / Receptors, Tumor Necrosis Factor, Type II / Tumor Necrosis Factor-alpha / Up-Regulation
(Link to Search Site for Scientific Articles)
● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 14738872
Kazuhiro Omori, Koji Naruishi, Fusanori Nishimura, Hisa Yamada-Naruishi and Shogo Takashiba : High glucose enhances interleukin-6-induced vascular endothelial growth factor 165 expression via activation of gp130-mediated p44/42 MAPK-CCAAT/enhancer binding protein signaling in gingival fibroblasts., The Journal of Biological Chemistry, Vol.279, No.8, 6643-6649, 2003.
(Summary)
Diabetic patients are susceptible to severe inflammatory periodontitis manifesting as swollen gingiva with bleeding, but the underlying mechanism is not well understood. Our purpose was to determine the effect of a high glucose (HG) condition on the interleukin-6/soluble interleukin-6 receptor (IL-6/sIL-6R)-induced activation of signaling and vascular endothelial growth factor (VEGF) expression in human gingival fibroblasts (HGFs). In this study, HGFs were cultured for at least two passages under a normal glucose (NG; 5.5 mM) condition or high glucose (25 mM) condition. Importantly, the HG condition significantly induced expression of gp130 mRNA in HGFs compared with levels in control cells. Consistent with the expression of its mRNA, the HG condition also increased the expression of gp130 protein, and phosphorylation of the tyrosine residue by gp130 was enhanced significantly by IL-6/sIL-6R stimulation. Furthermore, the HG condition enhanced the IL-6/sIL-6R-induced phosphorylation of p44/42 MAPK and led to subsequent activation of CCAAT/enhancer binding protein in nuclei. In contrast, there was no significant difference in phosphorylation of JNK between the HG and NG condition. Interestingly, HGFs increased IL-6/sIL-6R-induced VEGF165 mRNA expression and VEGF165 secretion under the HG condition compared with levels under the NG condition. In contrast, the induction of VEGF165 secretion was partially inhibited by PD98059 (selective p44/42 MAPK inhibitor) under the HG condition. In addition, the VEGF165 secretion was completely inhibited by the combination of PD98059 and SP600125 (JNK inhibitor). Our findings suggest that the HG condition indirectly increases VEGF expression via activation of gp130-mediated p44/42 MAPK-CCAAT/enhancer binding protein signaling in HGFs. Thus, elevated VEGF secretion in HGFs under the HG condition may play a role in the development of the severe periodontitis observed in diabetic patients.
Angiogenesis is a common complication of organ-transplant rejection. One of the primary responsible molecules for enhanced angiogenesis is vascular endothelial growth factor (VEGF). Activated protein (AP)-1 is considered to play a key role in the transcription of VEGF. c-jun N-terminal kinase (JNK), one of the MAP kinase family members, plays a critical role in AP-1 activation. Thus, we tested the effect of a novel JNK inhibitor, SP600125, on VEGF production in fibroblasts. SP600125 significantly suppressed interleukin (IL)-6-induced production of VEGF in cultured fibroblasts. Cyclosporine A (CsA), a known in vitro anti-angiogenic reagent, partially mimicked this suppression. In fact, CsA suppressed IL-6-induced phosphorylation of JNK. The results indicate that although both SP600125 and CsA are anti-angiogenic by inhibiting VEGF production by way of a JNK-dependent pathway, the inhibitory effect was much stronger with the novel inhibitor of JNK than with CsA.
Fusanori Nishimura, Hisa Naruishi, Koji Naruishi, Teruo Yamada, Junzo Sasaki, Christoph Peters, Yasuo Uchiyama and Yoji Murayama : Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice., The American Journal of Pathology, Vol.161, No.6, 2047-2052, 2002.
(Summary)
Drug-induced gingival overgrowth, the chronic side effect of calcium antagonists, is frequently seen due to the increase in patients with hypertension, although the etiology of the disease is largely unknown. I-cell disease, which accompanies gingival overgrowth, is characterized by a deficiency in UDP-N-acetyl-glucosamine and is classified as one of the lysosomal storage diseases. Here, we hypothesized that a common mechanism may underlie the etiology of gingival overgrowth seen in patients treated with calcium antagonist and in patients with I-cell disease. A calcium antagonist, nifedipine, specifically suppressed cathepsin-L activity and mRNA expression, but not that of cathepsin-B in cultured gingival fibroblasts. The activity of cathepsin-L was suppressed up to 50% at 24 hours after treatment of the cells with the reagent. The selective suppression of cathepsin-L activity appeared not to be dependent on Ca(2+), since treatment of the cells with thapsigargin suppressed both cathepsin-B and -L activity. Mice deficient in the cathepsin-L gene manifested enlarged gingivae. Histological observation of the gingivae demonstrated typical features of acanthosis, a phenotype very similar to that of experimentally induced gingival overgrowth. Since cathepsin-L deficiency was reported to be associated with thickening of the skin, impaired cathepsin-L activity may play a key role in the establishment of skin and gingival abnormalities seen in I-cell disease. In addition, reduced cathepsin-L activity may play an important role in inducing drug-induced gingival overgrowth.
Koji Naruishi, S Takashiba, F Nishimura, H H Chou, H Arai, H Yamada and Y Murayama : Impairment of gingival fibroblast adherence by IL-6/sIL-6R., Journal of Dental Research, Vol.80, No.5, 1421-1424, 2001.
(Summary)
Interleukin-6 (IL-6) binds to human gingival fibroblasts (HGF) in the presence of a soluble form of IL-6 receptor (sIL-6R). We investigated the effects of IL-6 on the functions of HGF in the presence of sIL-6R. HGF changed their morphology from spindle-shaped to round, and detached from the culture dish by stimulation with IL-6/sIL-6R. In this condition, a signal transducer gp130 and a transcription factor Stat3 were phosphorylated, resulting in activation of transcription factors Stat3 and C/EBPbeta. Cytoskeletal beta-actin and adhesion molecule integrin-alpha5, a subunit of alpha5beta1 integrin (VLA-5), were found to possess potential binding domains for these transcription factors in their promoters. Accumulation of beta-actin and integrin-alpha5 mRNA decreased, contrary to the expectation of the induction of gene transcription. Furthermore, the decrease in their mRNAs was associated with reduced expression of both actin and VLA-5 proteins. These results suggest that the expression of VLA-5 and actin was down-regulated in HGF through an IL-6 signaling pathway, resulting in impairment of HGF adherence.
H Yamada, F Nishimura, K Furuno, Koji Naruishi, Y Kobayashi, S Takashiba and Y Murayama : Serum phenytoin concentration and IgG antibody titre to periodontal bacteria in patients with phenytoin-induced gingival overgrowth., Journal of the International Academy of Periodontology, Vol.3, No.2, 42-47, 2001.
(Summary)
Epileptic patients taking phenytoin with gingival-overgrowth and those without gingival-overgrowth were compared for daily drug dose, plasma total phenytoin concentration, plasma free-phenytoin concentration and serum IgG antibody titre against 13 periodontal bacteria. Significantly higher daily drug dose was noted in patients with gingival overgrowth (P < 0.05) when compared with those without overgrowth. In addition, both total and free forms of plasma phenytoin concentration were significantly higher in sera of patients with gingival growth than of those without overgrowth (P < 0.01). Strong positive correlation was found between daily drug dose and serum phenytoin concentration in patients with gingival overgrowth, while weak correlation was found in patients without gingival overgrowth, suggesting a difference in drug metabolism in these two groups. However, no differences were found in serum IgG antibody titres to 13 periodontal bacteria examined between two groups. These results suggest that metabolic ability of phenytoin is one of the factors for developing gingival overgrowth, and that periodontal infection may not be a primary causative factor for gingival overgrowth but act as an additive factor which increase tissue mass for this unwanted side effect.
H Ohe, S Takashiba, Koji Naruishi, H H Chou, H Yamada, F Nishimura, H Arai and Y Murayama : Tumor necrosis factor-alpha (TNF-alpha)-induced and interleukin-1 beta (IL-1 beta)-induced shedding of TNF receptors from gingival fibroblasts., Journal of Interferon and Cytokine Research, Vol.20, No.12, 1077-1082, 2000.
(Summary)
Tumor necrosis factor-alpha (TNF-alpha) exerts its functions by binding two different receptors (TNFR55 and TNFR75). Both TNFR55 and TNFR75 exist in cell-associated and soluble forms. Soluble TNF receptors (sTNFR), sTNFR55 and sTNFR75, are proteolytically shed upon inflammatory stimuli and then modulate various TNF-alpha bioactivities. As human gingival fibroblasts (HGF) can be potential targets for TNF-alpha in inflamed gingiva, we hypothesized that HGF partially modulate the cellular responses to TNF-alpha by regulating their own TNFR. In this study, the kinetics of expression of cell-associated and soluble forms of both receptors from cultured HGF in response to proinflammatory cytokines TNF-alpha and interleukin-1 beta (IL-1 beta) were investigated in vitro. Both TNF-alpha and IL-1 beta upregulated the gene expression of TNFR75 and did not affect that of TNFR55. TNF-alpha and IL-1 beta decreased binding of [(125)I]TNF-alpha to HGF. Moreover, TNF-alpha and IL-1 beta upregulated the release of sTNFR75 from HGF but not that of sTNFR55. These results suggest that HGF under inflammatory conditions may contribute to the inactivation of circulating TNF-alpha through the preferential induction and shedding of TNFR75.
(Keyword)
Antigens, CD / Binding, Competitive / Cells, Cultured / Fibroblasts / Gingiva / Humans / immunohistochemistry / Interleukin-1 / Iodine Radioisotopes / Receptors, Tumor Necrosis Factor / Receptors, Tumor Necrosis Factor, Type I / Receptors, Tumor Necrosis Factor, Type II / Tumor Necrosis Factor-alpha
H H Chou, S Takashiba, H Maeda, Koji Naruishi, F Nishimura, H Arai, H Lu and Y Murayama : Induction of intracellular interleukin-1 beta signals via type II interleukin-1 receptor in human gingival fibroblasts., Journal of Dental Research, Vol.79, No.9, 1683-1688, 2000.
(Summary)
The type II interleukin-1 receptor (IL-1RII) has been thought to be incapable of transducing signals to cells because of its short intracellular domain, while type I IL-1 receptor (IL-1RI) does transduce signals. Since over-expression of IL-1RII has been demonstrated to inhibit cytokine production in the fibroblastic cell line, it has been proposed to use IL-1RII to prevent IL-1-induced inflammation in connective tissue. In this study, trace amounts of IL-1RII mRNA expression were detected in human gingival fibroblasts (HGFs), which are affected by cytokines in inflammatory periodontal disease. Cloning of the cDNA encoding IL-1RII expressed in HGFs revealed 3 amino acid substitutions in the extracellular domain, when compared with the 408 residues predicted from human B-cells. Over-expression of IL-1RII on HGFs by gene transfer down-regulated the expression of IL-1 beta mRNA and IL-6 mRNA in response to IL-1 beta stimulation, while the expression of IL-8 mRNA was not affected. In the IL-1RII-transfected HGFs, phosphorylation of 25- and 74-kDa proteins was up-regulated upon IL-1 beta stimulation in the transfected HGFs. The phosphorylation of these proteins was suppressed by the addition of a neutralizing antibody against IL-1RII. These results suggest that the IL-1RII may regulate HGFs expression of cytokine mRNA upon IL-1 beta stimulation, possibly by altering the IL-1RI-dependent signals.
F Nishimura, Koji Naruishi, H Yamada, T Kono, S Takashiba and Y Murayama : High glucose suppresses cathepsin activity in periodontal-ligament-derived fibroblastic cells., Journal of Dental Research, Vol.79, No.8, 1614-1617, 2000.
(Summary)
The accumulation of extracellular matrices and integrins by high glucose has been reported in relation to diabetic complications. We previously reported that PDL cells expressed a higher amount of VLA-5 when cultured in high-glucose (4500 mg/L) medium than those cultured in low-glucose (1100 mg/L) medium. In this study, we aimed to address (1) whether this effect was mediated by the transcriptional level of the gene or the degradative level of the protein, and (2) whether this effect was mediated by TGF-beta. The results indicated that the level of mRNA encoding alpha5 integrin did not change in PDL cells regardless of the concentration of glucose. Alternatively, high glucose suppressed cathepsin B+L activity. Additionally, the level of mRNA encoding TGF-beta was not affected by high glucose, nor did an anti-TGF-beta neutralizing antibody have an effect on the expression of beta5 gene or cathepsin activity. Therefore, the effects of high glucose appeared to be mediated by impaired protein degradation, but not by autocrine TGF-beta.
Yoji Asahara, Fusanori Nishimura, Hisa Yamada, Koji Naruishi, Masatoshi Kataoka, Jun-ichi Kido, Toshihiko Nagata and Yoji Murayama : Mast cells are not involved in the development of cyclosporin A-induced gingival hyperplasia: a study with mast cell-deficient mice, Journal of Periodontology, Vol.71, No.7, 1117-1120, 2000.
(Summary)
A previous study suggested that mast cells (MC) are involved in the development of cyclosporin A-induced gingival hyperplasia, since an increased number of MC were observed in the tissue sections of enlarged gingiva. To determine the role of MC in gingival hyperplasia, an MC-deficient mouse model was used in the current study. MC-deficient mice (WBB6F1xW/Wv) and their littermates (+/+) were fed sucrose-containing diets supplemented with or without varying concentrations (300, 400, 500, 600 mg) of cyclosporin A/kg of diet. After 30 days, the mice were sacrificed and the degree of gingival hyperplasia was evaluated by the appearance of the gingiva. Tissue MC were stained with toluidine blue to confirm the presence or absence of MC in the enlarged gingiva. Both W/Wv and +/+ mice, when fed with 600 mg cyclosporin A/kg diet for 30 days, exhibited a similar degree of gingival hyperplasia, while other test mice or control mice did not. Toluidine blue staining of the tissue sections confirmed the presence of MC in the enlarged gingiva of the +/+ mice, but not the W/Wv mice. These results indicate that mast cells are not necessary in the development of cyclosporin A-induced gingival hyperplasia, and that the increased number of MC observed in the enlarged gingiva may be a secondary effect of gingival hyperplasia. We also conclude that a study of mice lacking certain molecules or cells would be quite useful in determining the molecules or cell types responsible for the pathogenesis of drug-induced gingival hyperplasia.
H Yamada, F Nishimura, Koji Naruishi, H H Chou, S Takashiba, M G Albright, S Nares, M A Iacopino and Y Murayama : Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts., Journal of Periodontology, Vol.71, No.6, 955-960, 2000.
(Summary)
The results indicate that, besides suggested effects of these drugs on gingival fibroblasts and/or on accumulated cells in the gingival tissues, extracellular matrix-degrading ability, particularly that by cathepsin L, is also suppressed by cyclosporin A and phenytoin in gingival fibroblasts, and that lysosomal enzyme plays an important role in the pathogenesis of drug-induced gingival hyperplasia.
Koji Naruishi, S Takashiba, H H Chou, H Arai, F Nishimura and Y Murayama : Role of soluble interleukin-6 receptor in inflamed gingiva for binding of interleukin-6 to gingival fibroblasts., Journal of Periodontal Research, Vol.34, No.6, 296-300, 1999.
(Summary)
Interleukin-6 (IL-6), frequently detected in periodontitis, is known to mediate important signals in the inflammatory cytokine network. Gingival fibroblasts (GF) secrete cytokines upon stimulation with inflammatory mediators. However, it is not clear if GF respond to IL-6. We examined the IL-6 receptor gene expression in GF. Furthermore, we tested whether GF are target cells for IL-6 by examination of binding of IL-6. GF were found to contain trace amounts of mRNA for IL-6 receptor (IL-6R), but had high levels of mRNA for 130-kDa glycoprotein (gp130), which is a signal transducer for IL-6/IL-6R complex. Based on this observation, we hypothesized that IL-6 could bind GF if exogenous soluble forms of IL-6R (sIL-6R) existed in the gingiva or culture condition. Thus, we investigated the existence of sIL-6R in gingiva using enzyme-linked immunosorbent assay and whether sIL-6R influenced the binding of IL-6 to GF in vitro. In inflamed gingiva, sIL-6R was detected and its concentration ranged from 150 to 700 pg/microgram protein. The sIL-6R enhanced the binding of IL-6 to GF in a dose-dependent manner. This enhancement was inhibited by an antibody against gp130, suggesting that the IL-6/sIL-6R complex bound to the fibroblasts via gp130. These data demonstrated that gingival fibroblasts can be target cells for IL-6 in the presence of appropriate amounts of sIL-6R. This situation may exist during inflammation in periodontal tissue.
Jun-ichi Kido, Mika Bandou, Yuji Inagaki, 生田 貴久, Yukari Kajiura, Yukiko Nakajima, Eijiro Sakamoto, Chie Wada -Mihara, Masami Ninomiya, 西川 泰史, Jung-Hwan Lew, Koji Naruishi and Toshihiko Nagata : Diagnosis of Periodontal Diseases using Biomarkers in Gingival Crevicular Fluid, Journal of Oral Health and Biosciences, Vol.29, No.1, 13-20, 2016.
(Summary)
Periodontal diseases cause an inflammation and degradation of periodontal tissues and missing of teeth. The incidence rate of periodontal diseases is high in middle-aged and elderly people.A reasonable diagnosis of periodontal diseases is very important to keep teeth, however, conventional examinations of periodontal diseases is not necessarily exact and objective. Gingival crevicular fluid (GCF) is an exudate secreted from periodontal tissues and contains many components including proteolytic enzymes, inflammatory cytokines, blood-associated proteins, cellular and bacterial fragments. Because some proteins in GCF are related to inflammation, tissue degradation and bone metabolism, those proteins have been studying as a diagnostic marker of periodontal diseases. GCF is noninvasively collected using a sterile paper strip and biomarkers are determined using enzyme-linked immunosorbent assay (ELISA) and enzyme activity assay. We identified calprotectin, an inflammationrelated protein, in GCF and calprotectin level in GCF from periodontitis sites was significantly higher than that of healthy control. Calprotectin level in GCF was positively correlated to gingival index and other biomarkers and decreased by periodontal treatments. Resistin is an adipocytokine and its level increases in some inflammatory diseases. Resistin level in GCF from periodontitis sites was high compared to the level of healthy control samples. Procollagen type I C-terminal peptide (PICP) is a biomarker for bone metabolism and its level was high in GCF collected from periodontitis sites. These results suggested that calprotectin, resistin and PICP are useful biomarkers for periodontal diseases. On the other hand, we showed that glycated albumin (GA), a marker of diabetes mellitus (DM), was contained in GCF and GA level in GCF from DM patients was significantly higher than that of non-DM individuals. Components in GCF may be biomarkers of systemic diseases as well as periodontal diseases and their determination will be useful diagnostic examination of some diseases. Recently, we have been studying the determining system of GCF calprotectin, including microchip ELISA, surface plasmon resonance assay and immuno-chromatography assay. When GCF biomarkers are determined using the determining systems, we will simply, exactly and objectively diagnose periodontal diseases at our dental offices.
Osamu Murai, Daisuke Sasaki, Yoshinori Ando, Akira Fujimura, Hiromi Oikawa, Nagisa Suwa, Daisuke Watabe, Fumihiko Maeda, Kohki Endo, Takashi Yaegashi, Toshihide Akasaka and Koji Naruishi : Improvement of pustulosis palmaris et plantaris by periodontal infection control in a patient with chronic periodontitis., Clinical Laboratory, Vol.58, No.3-4, 323-327, 2012.
(Summary)
Pustulosis palmaris et plantaris (PPP) is a chronic, inflammatory, autoimmune-type disease characterized by sterile pustules of skin. The skin inflammation is influenced by several factors such as drugs, sunlight, metabolic and psychogenic factors as well as metal allergy. Here, we report a rare case that intensive periodontal treatment might have contributed to the improvement of skin inflammation. Skin inflammation regressed 1 month after intensive periodontal treatment. Both CD4/CD8 ratio and % of B cells in the blood sample were slightly decreased corresponding to the improvement of periodontal inflammation. Infection control of periodontal lesions might be one of attractive therapeutic targets in management of PPP.
(Keyword)
B-Lymphocytes / C-Reactive Protein / CD4-CD8 Ratio / Chronic Periodontitis / Humans / Leukocyte Count / Male / Middle Aged / Psoriasis / microcirculation of the skin
(Link to Search Site for Scientific Articles)
● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22582507
Koji Naruishi, Shunsuke SAWADA, Osamu MURAI, Yasunori TAKEDA, Takashi KAWAMURA, Kae WAKABAYASHI, Yukinori KUWASHIMA, Hiroyuki MIURA and Kazushi KUNIMATSU : A Case of Root of Apexification in Extruded-Immature Permanent Incisor, Dental Journal of Iwate Medical University, Vol.36, No.1, 53-58, 2011.
(Summary)
Calcium hydroxide is a suitable reagent for apexification procedures in immature permanent teeth. We report on a case of root apexification in a patient (8-yr, male) with a traumatic extrusion of the maxillary right central incisor. After temporary fixation of the traumatically extruded maxillary right central incisor, tooth necrosis and gingival swelling was observed , thus it was diagnosed to require an apexification procedure. The apexification procedure was successfully performed using calcium hydroxide following endodontic treatment. None of the calcium hydroxide -treated tooth showed any clinical or radiographic pathology. Additional follow-up time (2-3 years) is required to determine the final outcome of root canal therapy applied in cases of traumatized maxillary permanent incisor teeth with incomplete root formation.
Koji Naruishi and Kazushi KUNIMATSU : A Case Report of Severe Chronic Periodontitis Evaluated by Serum IgG Antibody Titer Test against Periodontal Pathogens, Dental Journal of Iwate Medical University, Vol.35, No.3, 146-152, 2010.
(Summary)
Chronic periodontitis is a polymicrobial infectious disease which may result in loss of teeth by inflammation-mediated bone resorption. More than 500 individual cultivable species of microbes have been identified in the human mouth, and the microbiological examinations for periodontitis have been available to dental clinicians since the late 1980s. Infection with periodontal pathogens leads to humoral immunological responses and elevates the levels of serum IgG antibody to the antigens. Since serum IgG antibodies levels correspond to the amount of periodontal bacteria, the effects of treatments focused on elimination of bacteria could be evaluated by decrease of serum IgG titer to the pathogens. In the present case report, we propose the clinical usefulness of serum IgG antibody levels as a marker for periodontal treatment effects.
Chieko KUDO, Takayuki KONO, Hidenori Nishimura, Hideki OHYAMA, Fumio MYOKAI, Koji Naruishi, Yoshihiro IWAMOTO, Naoki TAKAHASHI, Yoshihiko SOGA, Hideo ARAI, Yoji MURAYAMA and Shogo TAKASHIBA : A Case Report of Rheumatoid Arthritis Patient with Severe Periodontitis Whose Inflammatory Marker Improved by Periodontal Treatment, The Japanese Journal of Conservative Dentistry, Vol.46, No.1, 110-117, 2003.
Eijiro Sakamoto, Yuka Hiroshima, Jun-ichi Kido, Yasufumi Nishikawa, Koji Naruishi, Rie Kido and Hiromichi Yumoto : Various roles of calprotectin in periodontal disease and its possibility as a diagnostic marker for periodontal disease, Journal of the Japanese Association of Periodontology, Vol.62, No.4, 193-199, Dec. 2020.
Koji Naruishi and Hiromichi Yumoto : 糖尿病と慢性腎疾患(CKD), 月刊糖尿病, Vol.11, No.4, 80-85, Oct. 2019.
4.
Koji Naruishi and Toshihiko Nagata : Biological effects of interleukin-6 on Gingival Fibroblasts: Cytokine regulation in periodontitis., Journal of Cellular Physiology, Vol.233, No.9, 6393-6400, Mar. 2018.
(Summary)
Periodontitis is a bacterial infectious disease, and many inflammatory cytokines regulate periodontitis pathophysiology through a crosstalk between tissue cells and immune cells. Interleukin (IL)-6 is an important cytokine involved in the regulation of host response to bacterial infection. Human Gingival Fibroblasts (HGFs) are the most abundant cells in gingival connective tissues. Various HGF responses to periodontal pathogens or inflammatory cytokines contribute to the development of periodontitis. Lipopolysaccharide derived from Porphyromonas gingivalis (Pg LPS) and IL-1 significantly increase IL-6 production in HGFs. However, IL-6 cannot function in HGFs without the soluble form of the IL-6 receptor (sIL-6R), because HGFs do not express sufficient cell surface IL-6R to bind appreciable levels of IL-6. Importantly, sIL-6R is essential for IL-6 signaling in HGFs, and the sIL-6R is produced by differentiated THP-1 cells treated with IL-6. Calprotectin, a heterodimer of S100A8 and S100A9, is released during inflammation and significantly induces IL-6 production in HGFs via toll-like receptor 4 (TLR4)/nuclear factor-kappa B (NF-B) signals. Calprotectin also induces sIL-6R production in differentiated THP-1 cells. IL-6 induces vascular endothelial growth factor (VEGF), matrix-metalloproteinase-1 (MMP-1), and cathepsin L production in HGFs in the presence of sIL-6R. Taken together, calprotectin-induced IL-6 production in HGFs may cause periodontitis progression through a crosstalk of fibroblasts and macrophages. There are many reports that examine how cytokines are released from HGFs to cause beneficial or harmful effects in inflamed periodontal lesions. This review explores the pathophysiology of periodontitis by focusing IL-6-mediated crosstalk of HGFs and macrophages.
Koji Naruishi and Yasufumi Nishikawa : Crosstalk of Gingival Fibroblasts and Macrophages in Inflammatory Cytokine Cascade: Potential Mechanisms of Periodontitis, Journal of Cell Signaling, Vol.2, No.2, e149, Jun. 2017.
Koji Naruishi and Toshihiko Nagata : 最新の知見から攻める!①歯周病と腎疾患はどう関係するの?, The Journal of Dental Hygiene, Vol.36, No.3, 304-305, Mar. 2016.
7.
Koji Naruishi and Toshihiko Nagata : 歯周病が生活習慣病に及ぼす影響, The Japanese Journal of Clinical Nutrition, Vol.126, No.3, 262-267, Mar. 2015.
8.
Kazuhiro Omori, Chieko Kudo, Koji Naruishi, Hiroshi Maeda and Shogo Takashiba : Basic Research to Clinical Dentistry:Potentiality of plasma IgG antibody titer test against to periodontal pathogens, Journal of the Japanese Association of Periodontology, Vol.55, No.1, 9-14, 2013.
C T Thompson, A S Tahir, L Li, M Watanabe, Koji Naruishi, G Yang, D Kadmon, J C Logothetis, P Troncoso, C Ren, A Goltsov and S Park : The role of caveolin-1 in prostate cancer: clinical implications., Prostate Cancer and Prostatic Diseases, Vol.13, No.1, 6-11, Jul. 2009.
(Summary)
Caveolin-1 (cav-1) is reportedly overexpressed in prostate cancer cells and is associated with disease progression. Specific oncogenic activities of cav-1 associated with Akt activation also occur in prostate cancer. A membrane-associated protein, cav-1, is nonetheless secreted by prostate cancer cells; results of recent studies showed that secreted cav-1 can stimulate cell survival and angiogenic activities, defining a role for cav-1 in the prostate cancer microenvironment. Serum cav-1 levels were also higher in prostate cancer patients than in control men without prostate cancer, and the preoperative serum cav-1 concentration had prognostic potential in men undergoing radical prostatectomy. Secreted cav-1 is therefore a potential biomarker and therapeutic target for prostate cancer.
Koji Naruishi : Gingival Fibroblasts-mediated Pathophysiology of Periodontal Diseases, Periodontitis and Drug-induced Gingival Overgrowth, Journal of the Japanese Association of Periodontology, Vol.51, No.1, 7-18, Mar. 2009.
Shogo Takashiba, Koji Naruishi and Yoji Murayama : Perspective of cytokine regulation for periodontal treatment: fibroblast biology., Journal of Periodontology, Vol.74, No.1, 103-110, Jan. 2003.
(Summary)
Efforts to understand the pathogenesis of periodontal diseases have been underway for decades. Studies of immunological aspects in addition to the structural components of gingival fibroblasts showed that the fibroblasts actively participate in immune and inflammatory events in periodontal diseases. Future strategies for the prevention and treatment of periodontal diseases should biologically regulate fibroblast activities. These cells are surrounded by monocyte-derived proinflammatory cytokines such as interleukin-1 beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), and lymphocyte-derived interleukin-6 (IL-6) in inflamed gingival tissue. Recent anti-cytokine therapy for inflammatory diseases including rheumatoid arthritis aimed to inhibit the binding of cytokines to targeted cells such as fibroblasts and condrocytes. IL-1beta and TNF-alpha are thought to be therapeutic targets because these cytokines are essential for the initiation of inflammatory immune reactions and are produced for prolonged periods in inflammatory diseases. IL-6 is also a target, because it is abundantly present in inflammatory lesions and activates fibroblasts in the presence of soluble IL-6 receptor. In addition, these cytokines accelerate gingival fibroblasts to produce collagenolytic enzymes, resulting in tissue destruction. Soluble receptors for IL-1beta and TNF-alpha are suggested to be candidates for therapeutic molecules, but soluble receptor for IL-6 is suggested to be a factor-stimulating fibroblast. This paper will review the utilization of soluble receptors specific to inflammatory cytokines which potentially stimulate fibroblasts to regulate biological events involved in the pathogenesis of periodontal diseases.
Yasufumi Nishikawa, Koji Naruishi, Jun-ichi Kido and Hiromichi Yumoto : Diabetic high-glucose condition enhances calprotectin-induced inflammatory responses in gingival fibroblasts, 97th General Session & Exhibition of the International Association for Dental Research (Vancouver, Canada), Jun. 2019.
2.
Yuji Inagaki, Kohei Nonaka, Ryosuke Takagi, Yasufumi Nishikawa, Rie Kido, Eijiro Sakamoto, Koji Naruishi, Jun-ichi Kido and Hiromichi Yumoto : Kanroin Extracts Prevent Alveolar Bone Resorption in Experimental Rat Periodontitis, 96th General Session & Exhibition of the International Association of Dental Research, Jul. 2018.
3.
Yuka Hiroshima, Eijiro Sakamoto, Kaori Abe, Kaya Yoshida, Koji Naruishi, Toshihiko Nagata, Yasuo Shinohara, Geczy Carolyn and Jun-ichi Kido : Advanced Glycation End-Products Increase Calprotectin in Human Gingival Epithelial Cells, The 95th General Session & Exhibition of the International Association for Dental Research (IADR), San Francisco, Mar. 2017.
4.
Eijiro Sakamoto, Yuji Inagaki, Jun-ichi Kido, Takagi Ryosuke, Koji Naruishi and Toshihiko Nagata : AGE and Porphyromonas gingival is-LPS Increase Sclerostin Expression in Osteocytes, International Association for Dental Research, Mar. 2017.
(Keyword)
periodontitis / diabetes mellitus / bone and mineral metabolism
5.
Jung-Hwan Lew, Koji Naruishi, Yukari Kajiura, Yasufumi Nishikawa, Jun-ichi Kido and Toshihiko Nagata : High glucose enhances IL-6-induced protease production in gingival fibroblasts, 94th General Session & Exhibition, International Association for Dental Research, Seoul, Jun. 2016.
6.
Yasufumi Nishikawa, Koji Naruishi, Yukari Kajiura, Jung-Hwan Lew, Jun-ichi Kido and Toshihiko Nagata : Calprotectin induced the expression of inflammation-related molecules in gingival fibroblasts, 94th General Session & Exhibition, International Association for Dental Research, Seoul, Jun. 2016.
7.
Yukari Kajiura, Koji Naruishi, Yukiko Nakajima, Yasufumi Nishikawa, Jung-Hwan Lew, Jun-ichi Kido and Toshihiko Nagata : High glucose enhaces P. gingivalis-induced cytokine production in THP-1 monocytes, 94th General Session & Exhibition, International Association for Dental Research, Seoul, Jun. 2016.
8.
Syotaro Yoshioka, Yoshiteru Tada, Junichiro Satomi, Kenji Yagi, Koji Naruishi, Kazuyuki Kuwayama, Keiko Kitazato, Takeshi Miyamoto, Yasuhisa Kanematsu, Masafumi Harada, Toshihiko Nagata and Shinji Nagahiro : Impact of Periodontal Disease and Bacteria on Intracranial Aneurysms, International Stroke Conference 2016, Los Angeles, Feb. 2016.
9.
Masami Ninomiya, Keiji Oishi, Hashimoto Mari, Koji Naruishi, Yamanouchi Kouji, Fukumura Yoshiaki and Toshihiko Nagata : A Cross-Sectional Study on the Severity of Periodontitis in Infective Endocarditis Patients, 11th Asian Pacific Society of Periodontology Meeting, Oct. 2015.
T Ikuta, Yukari Kajiura, Mika Bandou, Yuji Inagaki, Koji Naruishi, Jun-ichi Kido and Toshihiko Nagata : YKL-40 in gingival crevicular fluid from patients with periodontitis and diabetes., Euro Perio 2015, Jun. 2015.
11.
Koji Naruishi and Toshihiko Nagata : HGFs-macrophage crosstalk: sIL-6R secretion in THP-1 macrophages, 62th Annual Meeting of Japanese Association for Dental Reserch Abstract, Dec. 2014.
Proceeding of Domestic Conference:
1.
Jun-ichi Kido, Yuka Hiroshima, Rie Kido, Kaya Yoshida, Yuji Inagaki, Koji Naruishi and Hiromichi Yumoto : 人工合成したβ-defensin 2によるPorphyromonas gingivalisの付着抑制およびリポソーム封入と口腔上皮細胞への送達, 四国歯学会第60回例会, Jun. 2022.
2.
Jun-ichi Kido, Yuka Hiroshima, Rie Kido, Kaya Yoshida, Yuji Inagaki, Koji Naruishi and Hiromichi Yumoto : 人工合成したbeta-defensin 2によるPorphyromonas gingivalisの付着抑制およびリポソーム封入と口腔上皮細胞への送達, 第65回春季日本歯周病学会学術大会, Jun. 2022.
3.
Rie Kido, Eijiro Sakamoto, Yuka Hiroshima, Mika Bandou, Jun-ichi Kido, Takahisa Ikuta, Masami Ninomiya, Yuji Inagaki, Yasufumi Nishikawa, Yoritoki Tomotake, Koji Naruishi and Hiromichi Yumoto : イムノクロマト法を用いたカルプロテクチン測定による歯周病およびインプラント疾患の診断, 四国歯学会第59回例会, Mar. 2022.
4.
Yasufumi Nishikawa, Koji Naruishi, Masami Ninomiya, Yuta Uemura and Hiromichi Yumoto : 2次性咬合性外傷を有する広汎型重度慢性歯周炎患者に包括的歯周治療を行った一症例, 日本歯科保存学会2021年度秋季学術大会(第155回)プログラムおよび講演抄録集, Oct. 2021.
(Keyword)
侵襲性歯周炎
5.
Yuka Hiroshima, Rie Kido, Jun-ichi Kido, Yuji Inagaki, Koji Naruishi and Hiromichi Yumoto : 人工合成したLopocalin 2はPorphyromonas gingivalisの口腔上皮細胞への付着を抑制する, 第64回秋季日本歯周病学会学術大会, Oct. 2021.
6.
Koji Naruishi : 幸せな「人生の最終段階」を目指して，歯科医療が貢献できること, The Japanese Journal of Conservative Dentistry, 27, Jun. 2021.
7.
Jun-ichi Kido, Yuka Hiroshima, Rie Kido, Kaya Yoshida, Yuji Inagaki, Koji Naruishi and Hiromichi Yumoto : リポソームに封入したリポカリン2の口腔上皮細胞への送達, 第64回春季日本歯周病学会学術大会, May 2021.
8.
Takahisa Ikuta, Masami Ninomiya, 秋月 皆人, Yuta Uemura, Koji Naruishi and Hiromichi Yumoto : Examination of the effectiveness of Porphyromonas gingivalis type 2 fimbria detection system by PCR, 第64回春季日本歯周病学会学術大会プログラムおよび演題抄録集, Vol.63, 24, May 2021.
(Keyword)
PCR / Porphyromonas gingivalis
9.
AKIZUKI Minato, Masami Ninomiya, Yuta Uemura, Takahisa Ikuta, Koji Naruishi and Hiromichi Yumoto : Usefulness of rapid detection system of Porphyromonas gingivalis using PCR, 日本歯科保存学会第153回 2020年度秋季学術大会, Nov. 2020.
Jun-ichi Kido, Yuka Hiroshima, Rie Kido, Yuji Inagaki, Koji Naruishi and Hiromichi Yumoto : 無細胞蛋白質合成系を用いた抗菌ペプチドの合成とリポソーム封入, 日本歯科保存学会2020年度春季学術大会(第152回)(神戸), Jun. 2020.
11.
Yuka Hiroshima, Jun-ichi Kido, Rie Kido, Kaya Yoshida, Yuji Inagaki, Koji Naruishi and Hiromichi Yumoto : オーラルケアへの応用に関連するリポソームのデリバリー法の検討, 第63回春季日本歯周病学会学術大会, May 2020.
12.
Rie Kido, Yuka Hiroshima, Takahisa Ikuta, Yuji Inagaki, Mika Bandou, Koji Naruishi, Jun-ichi Kido and Hiromichi Yumoto : 最終糖化産物による口腔上皮細胞の Lipocalin2 発現誘導は好中球の遊走性とサイトカイン発現を 調節する, 第63回春季日本歯周病学会学術大会, May 2020.
Masami Ninomiya, Takahisa Ikuta, Koji Naruishi and Hiromichi Yumoto : 重度慢性歯周炎を有する血液透析患者に対して包括的歯周治療を行った一症例, 日本歯科保存学会 2019年度秋季学術大会(第151回), Nov. 2019.
(Keyword)
periodontal disease / dialysis / Periodontal treatment / Periodontal medicine
15.
Kohei Nonaka, Mika Bandou, Jun-ichi Kido, Yuji Inagaki, Eijiro Sakamoto, Koji Naruishi and Hiromichi Yumoto : ショウガオールはヒト歯肉線維芽細胞においてAGEs誘導性の酸化ストレスを抑制する, 第62回秋季日本歯周病学会学術大会 (北九州), Oct. 2019.
16.
Yuka Hiroshima, Jun-ichi Kido, Rie Kido, Kaya Yoshida, Yuji Inagaki, Koji Naruishi and Hiromichi Yumoto : オーラルケアへの応用を目指した抗菌ペプチド合成とリポソーム封入, 第62回秋季日本歯周病学会学術大会, Oct. 2019.
17.
Ryosuke Takagi, Eijiro Sakamoto, Yuji Inagaki, Koji Naruishi, Jun-ichi Kido and Hiromichi Yumoto : S100A9はMAPKおよびSTAT3経路を介して骨細胞におけるIL-6とRANKLの発現を調節する, 日本歯科保存学会 2019年度春季学術大会(第150回) (金沢), Jun. 2019.
18.
Masami Ninomiya, Eijiro Sakamoto, Koji Naruishi, Takahisa Ikuta, Ryosuke Takagi, Hatanaka Kazu, Okamoto Kentaro, Ono Shintaro, Takashiba Shogo and Hiromichi Yumoto : A Familial Case of Severe Periodontitis associated with Cyclic Neutropenia, Journal of the Japanese Association of Periodontology, Vol.61, 164, May 2019.
(Keyword)
Cyclic Neutropenia / Familial / Severe Periodontitis
19.
Rie Kido, Yuka Hiroshima, Takahisa Ikuta, Kaya Yoshida, Yuji Inagaki, Koji Naruishi, Kazumi Ozaki, Jun-ichi Kido and Hiromichi Yumoto : 最終糖化産物はヒト口腔上皮細胞のリポカリン2発現を増加する, 第62回春季日本歯周病学会学術大会, May 2019.
Masami Ninomiya, Ikuta Takahisa, Koji Naruishi and Hiromichi Yumoto : A case report of comprehensive periodontal treatment for a patient with infective endocarditis caused by oral bacteria, 日本歯科保存学会2018年度秋季学術大会(第149回), 163, Nov. 2018.
西川 泰史, Koji Naruishi, Yukari Kajiura, Jung-Hwan Lew, Jun-ichi Kido and Toshihiko Nagata : カルプロテクチンはヒト歯肉線維芽細胞のTLR4を介して炎症性関連因子の発現を亢進する, 第144回日本歯科保存学会春季学術大会, Jun. 2016.
36.
Jung-Hwan Lew, Koji Naruishi, Yukari Kajiura, 西川 泰史, Jun-ichi Kido and Toshihiko Nagata : カロテノイドは高グルコース下で培養したヒト歯肉線維芽細胞のIL-6誘導性タンパク分解酵素産生を抑制する, 第59回春季日本歯周病学会学術大会, May 2016.
37.
Jun-ichi Kido, Mika Bandou, Yukiko Nakajima, Yukari Kajiura, Yuji Inagaki, 生田 貴久, Eijiro Sakamoto, Koji Naruishi and Toshihiko Nagata : ヒト口腔上皮細胞と歯肉線維芽細胞において低酸素環境が誘導する遺伝子発現の比較, 第143回日本歯科保存学会秋季学術大会, Nov. 2015.
38.
吉岡 正太郎, Yoshiteru Tada, Kazuyuki Kuwayama, Kenji Yagi, Junichiro Satomi, 宮本 健志, 北里 慶子, Koji Naruishi, Toshihiko Nagata, Masafumi Harada and Shinji Nagahiro : 歯周病の重症度および原因菌は脳動脈瘤の発生と破裂に関与する, 一般社団法人 日本脳神経外科学会第74回学術総会, Oct. 2015.
39.
Yukari Kajiura, Jun-ichi Kido, Yukiko Nakajima, Mika Bandou, Yuji Inagaki, Koji Naruishi, Eijiro Sakamoto, Kaori Abe, Yuka Hiroshima and Toshihiko Nagata : 低酸素環境が誘導するヒト口腔上皮細胞における遺伝子発現の解析, 第58回秋季日本歯周病学会学術大会, Sep. 2015.
40.
Eijiro Sakamoto, Jun-ichi Kido, Yukari Kajiura, Mika Bandou, Yuji Inagaki, Koji Naruishi, 生田 貴久 and Toshihiko Nagata : 最終糖化産物はヒト口腔上皮細胞の遺伝子発現を調節する, 第58回秋季日本歯周病学会学術大会, Sep. 2015.
41.
Koji Naruishi, Yukari Kajiura, 西川 泰史, Mika Bandou, Jun-ichi Kido and Toshihiko Nagata : 培養歯肉線維芽細胞におけるクリプトタンシノンによる炎症関連分子の生産抑制効果, 第142回日本歯科保存学会春季学術大会, Jun. 2015.
42.
西川 泰史, Koji Naruishi, Yukari Kajiura, Mika Bandou, Jun-ichi Kido and Toshihiko Nagata : カルプロテクチンがヒト歯肉線維芽細胞の炎症関連因子の発現に及ぼす影響, 第58回春季日本歯周病学会学術大会, May 2015.
Masami Ninomiya, Keiji Oishi, Hashimoto Mari, Koji Naruishi and Toshihiko Nagata : A Cross-Sectional Study on the Progression of Periodontitis in Infective Endocarditis Patients, 日本歯科保存学会 2014年度秋季学術大会(第141回), Oct. 2014.
澤田 俊輔 and Koji Naruishi : 高血糖状態で培養したヒト歯肉線維芽細胞の網羅的な遺伝子解析(一般演題,岩手医科大学歯学会第71回例会抄録), Dental Journal of Iwate Medical University, Vol.36, No.1, 80-81, May 2011.
Norihiro SONOI, Hiroshi MAEDA, Koji Naruishi, Susumu KOKEGUCHI, Amgad Wael HASSAN, Koichi SAWADA, Yasushi KOIDE, Kokoro YAMABE, Ichiro TANIMOTO, Hideo ARAI and Shogo TAKASHIBA : A role of the nrdD-like gene related to abscess-forming ability of Porphyromonas gingivalis, The Japanese Journal of Conservative Dentistry, Vol.51, 25, May 2008.
Takashi TOMIYAMA, Koji Naruishi, Rosalia MARTINEZ Zulema ARIAS, Keisuke YAMASHIRO, Hiroshi MAEDA, Hideo ARAI and Shogo TAKASHIBA : Pathophysiology of Periapical Lesions during Root Canal Treatment based on Microarray Analysis in Experimental Rat Periapical Lesions, The Japanese Journal of Conservative Dentistry, Vol.51, 141, May 2008.
Arias Zulema Rosalia MARTINEZ, Koji Naruishi, Keisuke YAMASHIRO, Kaori MATSUURA, Naoko NAMBA, Hiroshi MAEDA, Hideo ARAI and Shogo TAKASHIBA : Gene Profiles during Root Canal Treatment in Experimental Periapical Lesions, The Japanese Journal of Conservative Dentistry, Vol.50, 155, May 2007.
Hideo ARAI, Ichiro TANIMOTO, Yoshihiro IWAMOTO, Yasushi KOIDE, Kazuya TOMIKAWA, Takashi TOMIYAMA, Masayuki SHIMOE, Norihiro SONOI, Koji Naruishi and Shogo TAKASHIBA : Evaluation of E-learning System for Clinical Education of Periodontology & Endodontology, The Japanese Journal of Conservative Dentistry, Vol.49, 175, Oct. 2006.
Tomoko YAMAGUCHI, Koji Naruishi, Hideo ARAI, Hidenori Nishimura and Shogo TAKASHIBA : Caveolin-1 Mediates IL-6/sIL-6R-induced Cathepsin-B, -L Activation in Human Gingival Fibroblasts, Journal of the Japanese Association of Periodontology, Vol.48, 149, Mar. 2006.
Keisuke YAMASHIRO, Koji Naruishi, Akiko YAMASHITA, Kyoko SENOO, Tomoko YAMAGUCHI, Fumio MYOKAI, Hideo ARAI, Hidenori Nishimura and Shogo TAKASHIBA : Microarray Analysis of Gene Expression Profiles Induced by High Glucose in Human Gingival Fibroblasts, Journal of the Japanese Association of Periodontology, Vol.48, 197, Mar. 2006.
Kazuhiro OMORI, Koji Naruishi, Hidenori Nishimura, Hisa NARUISHI YAMADA, Mayumi YAMAGUCHI, Hideo ARAI and Shogo TAKASHIBA : High glucose enhances IL-6 induced VEGF expression via activation of gp130 mediated p44/42 MAPK-C/EBP signaling in human gingival fibroblasts, Journal of the Japanese Association of Periodontology, Vol.45, 139, Sep. 2003.
Mayumi YAMAGUCHI, Hidenori Nishimura, Koji Naruishi, Kazuhiro OMORI, Hisa NARUISHI and Shogo TAKASHIBA : Anti-angiogenic Effect of Cyclosporine-A is Mediated by the Suppression of VEGF Production via Decreased JNK Activity, Journal of the Japanese Association of Periodontology, Vol.45, 140, Sep. 2003.
Mayumi YAMAGUSHI, Hidenori Nishimura, Hisa NARUISHI, Yoshihiko SOGA, Susumu KOKEGUCHI, Koji Naruishi and Shogo TAKASHIBA : Lipopolysaccharide from Periodontal Bacteria Enhances TNF- Production in 3T3-L1 Adipocytes, Journal of the Japanese Association of Periodontology, Vol.45, 96, Apr. 2003.
Kazuhiro OMORI, Koji Naruishi, Hidenori Nishimura, Hisa YAMADA-NARUISHI, Mayumi YAMAGUCHI, Hideo ARAI and Shogo TAKASHIBA : High glucose enhances IL-6/sIL-6R induced VEGF production in human gingival fibroblast, The Japanese Journal of Conservative Dentistry, Vol.45, 60, Oct. 2002.
Hidenori Nishimura, Hisa Naruishi, Koji Naruishi, Shogo Takashiba and Yoji Murayama : Cathepsin-L deficient mice develop gingival overgrowth, Journal of the Japanese Association of Periodontology, Vol.44, No.0, 91, Sep. 2002.
Hisa YAMADA, Hidenori Nishimura, Koji Naruishi, Shogo TAKASHIBA and Yoji MURAYAMA : Ca^<2+> Blocker Nifedipine Suppress Cathepsin L Activity in Gingival Fibroblasts in vitro, The Japanese Journal of Conservative Dentistry, Vol.44, 96, Apr. 2001.
Koji Naruishi, S. TAKASHIBA, Hidenori Nishimura, H. YAMADA, H. ARAI and Y. MURAYAMA : Regulation of Cathepsin B and L Activation via IL-6/sIL-6R-Induced p44/42 MAPK in Gingival Fibroblasts, Journal of the Japanese Association of Periodontology, Vol.43, No.0, 159, Mar. 2001.
Yoshihiko SOGA, Hidenori Nishimura, Kyoko KATSURAGI, Koji Naruishi, Hisa YAMADA, Hideaki SATO, Shogo TAKASHIBA and Yoji MURAYAMA : An Early-Onset Periodontitis Patient with Aberrant Expression of 2-integrin, The Japanese Journal of Conservative Dentistry, Vol.42, 77, Oct. 1999.
Hisa YAMADA, Hidenori Nishimura, Koji Naruishi, Yoshitomo KOBAYASHI, Shogo TAKASHIBA and Yoji MURAYAMA : Oral Disease Status of the Patients Receiving Phenytoin Therapy, The Japanese Journal of Conservative Dentistry, Vol.42, 203, Oct. 1999.
Shogo TAKASHIBA, Taisuke OHIRA, Fumio MYOKAI, Masataka OYAMA, Koji Naruishi and Yoji MURAYAMA : Genes Expressed Uniquely during Wound Healing in Dental Pulp Tissue, The Japanese Journal of Conservative Dentistry, Vol.42, 17, Apr. 1999.
Masataka OYAMA, Koji Naruishi, Taisuke OHIRA, Fumio MYOKAI, Shogo TAKASHIBA and Yoji MURAYAMA : Experimental Studies on Gene Transfer to Dental Pulp Cells, The Japanese Journal of Conservative Dentistry, Vol.42, 18, Apr. 1999.
Akemi SHIMIZU, Hidenori Nishimura, Koji Naruishi, Satoko SAWADA, Chiyo FUJIMOTO, Junji MINESHIBA, Shogo TAKASHIBA and Yoji MURAYAMA : A Case Study of Compromized Host Who Died After Periodontal Treatment, Journal of the Japanese Association of Periodontology, Vol.41, No.1, 180, Mar. 1999.
H. Ohyama, Hidenori Nishimura, Koji Naruishi, S. Takashiba and Y. Murayama : The roles of HLA class II molecules expressed on periodontal ligament cells, Journal of the Japanese Association of Periodontology, Vol.41, No.0, 89, Mar. 1999.
Hyogo Ohe, Koji Naruishi, Norifumi Washio, Hideo Arai, Hidenori Nishimura, Shogo Takashiba and Yoji Murayama : Production of Soluble TNF Receptor form Human Gingival Fibroblasts Stimulated by Inflammatory Cytokines, Journal of the Japanese Association of Periodontology, Vol.41, No.0, 107, Mar. 1999.
Fumio MYOKAI, Taisuke OHIRA, Tadashi YAMAMOTO, Junji MINESHIBA, Norifumi WASHIO, Koji Naruishi, Hideo ARAI, Hidenori Nishimura, Shogo TAKASHIBA and Yoji MURAYAMA : Study of Unique Genes Expressed by Mechanical Stress in Human Periodontal Ligament Fibroblasts, Journal of the Japanese Association of Periodontology, Vol.40, No.0, 108, Sep. 1998.
Hisa Yamada, Hidenori Nishimura, Koji Naruishi, Shogo Takashiba and Yoji Murayama : Cyclosporin A and phenytoin suppress matrix-degrading enzyme activity in gingival fibroblasts in vitro, Journal of the Japanese Association of Periodontology, Vol.40, No.0, 112, Sep. 1998.
Taisuke OHIRA, Fumio MYOKAI, Koji Naruishi, Tadashi YAMAMOTO, Hideo ARAI, Hidenori Nishimura, Shogo TAKASHIBA and Yoji MURAYAMA : Expression Pattern of Serum and Glucocorticoid-Inducible Kinase (sgk) during Rat Dental Hard Tissue Formation, The Japanese Journal of Conservative Dentistry, Vol.41, 32, May 1998.
Koji Naruishi, Shogo TAKASHIBA, Masayuki TAKIGAWA, Hidenori Nishimura, Hideo ARAI and Yoji MURAYAMA : IL-6-induced signals via soluble IL-6 receptor in gingival fibroblasts, The Japanese Journal of Conservative Dentistry, Vol.40, 62, May 1997.
Hiromasa OMURO, Masayuki TAKIGAWA, Kazunori OKAMURA, Hidenori Nishimura, Koji Naruishi, Takamasa SAWA, Tadashi YAMAMOTO, Taisuke OHIRA, Keiso TAKAHASHI, Shun Guo JUAN, Shogo TAKASHIBA and Yoji MURAYAMA : A Case Study of family Members Manifesting Early-Onset Periodontitis with Gingival Overgrowth ~Clinical, Microbiological, Immunological and Histological Observation~, The Japanese Journal of Conservative Dentistry, Vol.40, 154, May 1997.
Koji Naruishi, Hideo Arai, Shogo Takashiba, Masayuki Takigawa, Norifumi Washio, H.Hsin-Hua Chou, Hyogo Ohe, Yoji Asahara, Yutaka Higuchi, Hidemi Kuriahra and Yoji Murayama : Role of Soluble IL-6 Receptor on IL-6 Signal Transduction in Human Gingival Fibroblast, Journal of the Japanese Association of Periodontology, Vol.37, No.0, 96, Apr. 1995.
Pathophysiology of periodontitis progression by IL-1 and geriatric impaired testosterone in diabetic patients (Project/Area Number: 19K10131 )
Basic study for oral care system using an artificial cell (Project/Area Number: 17H04418 )
Crosstalk of Gingival Fibroblasts and Macrophages in Inflammatory Cytokine Cascade: Potential Mechanisms of Periodontitis with Diabetes. (Project/Area Number: 16K11832 )
Diagnosis of peri-implant diseases by cellular biomarkers and development of diagnostic device (Project/Area Number: 15K15767 )
Effect of advanced glycation end-products and inflammasome for pathogenesis of Diabetes mellitus-associated periodontitis (Project/Area Number: 15K11391 )
Pathophysiology of diebetes-associated periodontitis and establishment of novel diagnosis system of diabetes-associated periodontitis (Project/Area Number: 15H05054 )
How periodontitis can affect prostate cancer metastasis? (Project/Area Number: 22592312 )
Chronic infection and immune response in COPD patients (Project/Area Number: 21590964 )
Investigation of the mechanisms of osteogenic differentiation by RhoA in periodontal ligament cells for cell transplantation (Project/Area Number: 20592429 )
Possible Mechanisms of Progression of Periodontits by MMP-3 in Diabetic Patients (Project/Area Number: 20592428 )
Healing mechanism of rat experimental periapical lesions targeting laminin γ2 expression (Project/Area Number: 20592226 )
New bactericide delivery system for oral care (Project/Area Number: 19592201 )